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1. INTRODUCTION 
It is sometimes necessary to terminate a pregnancy prior to term 
whereas premature deliveries have to be prevented whenever possi­
ble. In such clinical situations it is important to be informed 
about the degree of pulmonary maturation, because post partum 
the lungs are responsible for the gas exchange, a function which 
is performed by the placenta during intrauterine life. 
Several methods are described in the literature on how to obtain 
information about fetal lung maturity (see chapter 4 ) . However, 
most of these are time-consuming and divergent. Both false posi­
tive and false negative results occur in all of the described me­
thods. Maternal and/or fetal conditions can influence the results 
as can maternal drug administration. Such influences can not al­
ways be ruled out and the tests may also be falsely interpreted 
under these conditions. Besides, if the neonate remains alive it 
is often difficult to assess the degree of respiratory distress. 
The determination of the amount of surface active substances in 
amniotic fluid makes it possible to form an opinion on the func­
tion of the lungs during early neonatal life. 
In 1927 Kurt von Neergaard stated that the lack of elasticity of 
lung tissue was not the only factor responsible for atelectasis 
in early premature neonates. However, it took another thirty 
years before Pattle (1955, 1958) and Clements (1957) pointed out 
the importance of the so-called surfactant. This substance is 
mainly composed of phospholipids (Scarpelli, 1967). Avery 4 Mead 
(1959) found a strongly surface active substance in the lungs of 
normal neonates, which was absent in the lungs of newborns suf­
fering from the respiratory distress syndrome (RDS). The main 
component of this surfactant was identified as dipalmitoyl phos­
phatidylcholine (Gluck et al., 1970). 
The origin of surfactant has been discussed extensively in the 
literature and its major component, lecithin, is produced by the 
fetal lung (Biqgs et al., 1973). 
It has also been shown that the amount of another phospholipid 
of amniotic fluid, sphingomyelin, remains almost stable during 
pregnancy. This has led to the introduction of the lecithin/ 
sphingomyelin ratio which has become β well known method of de­
termining fetal pulmonary maturation. The test was extended with 
the analysis of other surface active substances (the so-called 
lung profile, Hallman et al., 1976). 
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Not only the amount but also the composition of amniotic fluid 
changes during pregnancy (Fairweather 4 Eakes, 197Θ). For example 
under normal circumstances the amount of protein decreases from 
the 28th week of pregnancy to term, as does the bilirubin con­
tent. The concentration of other substances increase during preg­
nancy (e.g. lecithin and other surface active substances, Creati­
nin, amylase). Not all changes are fully understood, but some of 
them are related to the maturity of the fetal organs. 
This thesis is the result of investigations which were performed 
in order to answer the following questions: 
1) What is the course of the L/S ratio in human pregnancies and 
is it possible to devise a statistical model of the process. 
Do maternal and/or fetal conditions affect this course and 
what is the predictive value of the L/S ratio with respect to 
the origin of the respiratory distress syndrome? 
2) Is there any advantage for the clinician in using the total 
lung profile instead of the one-dimensional L/S ratio for the 
evaluation of lung maturation? 
3) Can the amylase content of amniotic fluid be used as a predic­
tor of lung maturity? 
4) How does the L/S ratio change in Macaca arctoides during preg-
nancy and is there an influence of Ambroxol^ medicati on on the 
L/S ratio in this species? 
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2. THE FETAL LUNG: PREPARATION FOR EARLY NEONATAL LIFE 
In order to achieve sufficient oxygen transport the respiratory 
system must: (1) exhibit a cellular maturity; (2) be capable of 
clearing the lung liguid; (3) be able to maintain continuous res-
piratory muscle function after birth (Meloney, 1 9 8 4 ) . 
2.1. Embryology and anatomy 
The primordium of the respiratory system appears in the 6th week 
(MA) as an outgrowth from the ventral wall of the foregut in em-
bryos of about 25 somites. This median ventral diverticulum of 
the foregut is called the tracheobronchial groove which soon be-
comes separated from the foregut by the esophagotracheal septum. 
The respiratory primordium grows caudally and forms the trachea 
and the bifurcating lung bud. After the 6th week (MA) two primary 
bronchial branches appear. These buds grow into the surrounding 
beds of mesenchyme which supply the vasculature for the develo-
ping bronchi. The lobar bronchi appear as outgrowths of the pri-
mary bronchi and afterwards the conducting airways are formed by 
an asymmetric dichotomous branching process. By the 12th week 
(MA) all characteristic features of the respiratory tract are 
present. During further development the bronchi repeatedly divide 
until about the 18th week (MA) (rglandular s t a g e ) . Up to this mo-
ment the air passages are closed. From then until 28 weeks (MA) 
the period is called the canalicular stage, during which the res-
piratory areas begin to be delineated and become vascularized. It 
results in functional, but primitive, gas exchange. 
After the 28th week (MA) the thin-walled alveoli are derived from 
the respiratory bronchioles (= terminal s t a g e ) . Once this stage 
has been completed, there is a sufficient area of gas exchange 
for survival of the fetus. 
By the 15th week (MA) potential airways are embedded in loosely 
arranged mesenchyme. The mucosa of the most proximal bronchioles, 
already shows longitudinal folds, which are lined with a pseudo-
stratified ciliated columnar epithelium. This is interspersed 
with tall, non-ciliated secretory cells. As the airways proceed 
distally, they become lined almost exclusively with non-ciliated 
cells, and finally the terminal budding airway is lined with a 
cuboidal epithelium of undifferentiated cells. The cuboidal epi-
thelium becomes markedly attenuated and flattened with the rapid 
proliferation of the underlying tissue and vascular structures. 
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It differentiates further into two distinct epithelial cell ty­
pes: type I cells, which are supporting cells with small perinu­
clear bodies and large pytoplasmic extensions, and type II cells, 
which are much larger, rounded, without any extension end which 
produce the lamellar inclusion bodies. 
Between the 24th and 26th week (MA) preparation for extra-uterine 
life continues with the development of many lamellar inclusions 
in the cells lining the distal airways. These lamellae appear in 
the previously mentioned type II alveolar cells. 
After the 26th week (MA) the fetus prepares for successful air 
breathing. Terminal spaces make up the majority of the cross sec­
tional area of the lung and many capillary walls touch flattened 
epithelial surfaces. Mature type II cells actively secrete surfa­
ce active material into the air spaces by exocytosis. The distan­
ce between the terminal air spaces, however, is still wide and is 
filled with scattered fibroblasts and collagen bundles. The alve­
olar ducts develop distally, where they open into terminal saccu­
les. These are lined with mature type II cells which are inter­
spersed with many capillaries stretching under mature type I 
eel Is. 
After the 32nd week (MA) the fetus begins to alveolize the lung 
guite rapidly with many air saccules arising terminally from al­
veolar ducts as well as from more proximal respiratory bronchio­
les. The saccules are somewhat thick-wa 1 ledj many type II cells 
appear and these are already guite mature. True alveoli zation 
occurs after the 36th week (MA); growth of the lung takes place 
predominantly through formation of new alveolar units and the si­
ze of the lung increases rapidly. 
At term the lung has thin alveolar walls made up of adjacent ca­
pillaries. These form a ріехиз with little interstitial tissue at 
the alveolar level except at junctional areas where bundles of 
collagen and fibroblasts can be seen. The type I cells normally 
adhere tightly to the capillary epithelial wall from which they 
are separated by a basement membrane and an occasional fibroblast 
or loose collagen bundle. The type I alveolar cells cover 95^ of 
the surface of the alveolus. Type II cells, filled with membrane-
bound lamellar bodies and capped with tall microvilli, appear at 
j'unctional areas. Exocytosis is thought to пег и г by fusion of the 
limiting membrane of the lamellar bodies with the plasma membra­
nes. The lamellar membranes are spun out into the airspaces whiire 
they often appear as characteristic "basket-weave" types nf myp-
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lin figures. It із thought that they form a monolayer in close 
contact with the plasma membranes of the cells lining the alveo­
li. 
The above description is baaed on various studies of lung deve­
lopment (Campiche et al., 1963; Alcorn et al., 1974; Boyden, 
1977; Strang, 1977; Stahlman 4 Gray, 197В; Avery et al., 1981). 
2.2. Fetal breathing movements 
After the first publication on fetal respiratory movements 
(Ahlfeld, 1ΘΘΘ) several publications have appeared on this sub­
ject. Irregular changes in tracheal pressure and tracheal fluid 
flow were seen in fetal lambs (Dawes et al., 1970) providing evi­
dence of the activity of the respiratory system in utero. Fetal 
breathing activity has also been demonstrated in man where it is 
suppressed by hypoxia, low blood glucose level and smoking 
(Boddy, 1976). It seems that fetal breathing is almost exclusive­
ly diaphragmatic in type (Poore 4 Walker, 19Θ0). 
From the experiments of Wigglesworth 4 Desai (1979) it was con­
cluded that fetal breathing movements are necessary for normal 
lung growth. Probably, this is due to intermittent distention of 
the lungs with fluid aspirated into the trachea (Kitterman, 
1984). 
There is evidence that physical factors can Influence surfactant 
metabolism (Alcorn et al., 1977). However, Liggins et al. (1981) 
stated that the absence of or the decrease in amplitude of fetal 
breathing movements does not affect surfactant formation and re­
lease as judged from measurements of saturated phosphatidylcho­
line. Determination of whether physical stimuli of increased fe­
tal breathing movements affect surfactant will reguire further 
experiments. Fetal breathing movements have to be stimulated by 
methods which do not, in themselves, affect surfactant metabo­
lism. 
2.3. Phospholipids: composition and synthesis 
2.3.1. Source 
Adamson et al. (1969) showed that in amniotic fluid the surfac­
tant is a specific substance formed by the fetal lung. 
Although other authors found that there were also extra-pulmonary 
sites of synthesis of the phospholipids of amniotic fluid 
(Condorelli et al., 1974; Abramovic et al., 1975), Biggs et al. 
(1973, 1974) demonstrated that the main source of lecithin was 
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the fetal lung. Furthermore the phospholipid composition of amni­
otic fluid and tracheal effluent are similar (Gluck et al.1974b; 
Giudicelli et al., 1975). 
2.3.2. Composition 
Phospholipids are synthetized in the type II pneumocytes. The 
following components are required as precursors of these substan­
ces (Foliguet et al., 1978; Ohno et al., 197Θ; Batenburg & v. 
Golde, 1979): 
- fatty acids: directly from blood 
from lipoprotein synthesis 
synthesis from acetate 
- an-glycerol-3-phosphate: synthesis from glycogen via glucose 
rebuilding from glycerol 
- Choline: directly from blood. 
sn-Glyc*rOl-3-phosphal* 
Acyl-CoA. (Ш) 
Phosphatidylglycrrol 
^ . H j P O , 
(X) С 
l-Acyl-sn-glycerol-3 phosphate 
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C o A · — ^ 
1 2-0iacyl-sn-glycrrol Э phosphat« 
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Phosphalidyl-
glyce rol-phosphale 
с м р
* Л ( іі) ( i x ) / - - C M P 
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Ύ
0: . 
{ (VU Λ 
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(Phosphatidylcholine Lecithin) · 
pbos^ìale. 
С Т Р ^ 
С о А ^ 
(XD) j ) 
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A T P -
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Figure 2.1. Biosynthesis of phospholipids (Reproduced from Ohno 
et al., 197Θ) 
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Table II.I. The enzymes involved in the synthesis of phospholi-
pids (reproduced from Ohno et el., 1978) 
A De novo synthesis of phospholipids 
1 De novo synthesis of lecithin and phosphatidyl-ethanolamine 
(I) ATP choline phosphotransferase (choline kinase) 
(0 ATP ethanolamine phosphotransferase (ethanolamine kinase) 
(II) CTP phosphorylcholme cyMyltransferase (phosphoiylcholme cytKJyltransferase) 
(II") CTP phosphorylethanolamine cytidyltransferase (phosphorylethanolamme cyttdyt-
transferase) 
(III) Acyl-CoA sn-glycerol-3-phosphate acyltransferase (glycerol-phosphate acyltrana-
ferase) 
(IV) Acyl-CoA 1-acyl-sn-glycerol-3-phosphate acyltransferase [(1-acyl) lysophosphatl-
date acyltransferase] 
(V) Phosphatidic acid phosphohydrolase (phosphatidate phosphatase) 
(VI) CDP-cholme 1 ¿-diacyl-sn-glycerol-chohnephosphotransferase (diglycende choline-
phosphotransferase) 
(VI*) CDP-ethanolamme 1,2-diacy1-sn-glycerol-ethanolamine-phosphotransferase(diglyc· 
ende ethanolamine-phosphotransferase) 
2 De novo synthesis of acidic phospholipids 
(VII) CTP phosphatidic acid cytidyltransferase (phosphatidate-cytidyltransferase) 
(VIII) COP-diglycende mositol-phosphatidyltransferase (mositol-phosphatidyltrans-
ferase) 
(IX) CDP-diglycende sn-glycerol-3-phosphate phosphatidyltransferase (glycerolphos· 
phate phosphatidyltransferase) 
(X) Phosphatidylglycerol phosphate phosphohydrolase (phosphatidylglycerolphosphate 
phosphatase) 
В Synthesis of lecithin by methylabon 
(XI) s-Adenosylmethionme phospholipids methyltransferases 
(XI-1) s-Adenosylmethionme phosphatidyl-ethanolamine methyltransferase 
(XI-2) s-Adenosylmethionme- phosphatidyl-MME and phosphatidyl-DME methyltrans­
ferase« 
С Synthesis of lecithin by acyiebon of lysolecithm 
(XII) Acyl-CoA lysolecithm acyltransferases 
(XII-1) Acyl-CoA (l-acyl)lysolecithin acyltransferase 
(XII-2) Acyl-CoA (2-acyl)lysolecithin acyltransferase 
D Synthesis of lecithin by transacylstion between two molecules of lysolecithm 
(XIII) (l-Acyl)lysolecithin (l-acyl)lysolecithin acyltransferase 
• MME, monomethylethanolamme DME, dimethylethanolamme 
The formation of phosphatidic acid ( 1,2-diacy1-sn-qlycero 1-3-
phosphate) is the first step in the phospholipid-synthesis. This 
intermediate may be formed via two different pathways (figure 
2. 1. , table II.I. ): 
1. Stepwise acylation of L-qlycerophosphate by activated fatty 
acyl groups, catalysed by acyltransferase. 
2. Conversion of dihydroxyacetonephosphete to acyldlhydroxy-ace-
tonephosphate, which is subsequently reduced and then further 
acylated to phospatidic acid. 
Two different pathways are responsible for the biosynthesis of 
lee i thin: 
1. Ethanolamine incorporation pathway (before the 34th week (MA) 
of preqnancy). 
2. Choline incorporation pathway (after the 34th week (MA) of 
preqnancy) 
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Previous studies suggested that the methylation pathway was of 
major importance for the lecithin synthesis in the premature fe-
tal lung; however, it has now been convincingly demonstrated that 
the choline incorporation pathway is always the primary mechanism 
for the synthesis of phosphatidylcholine in the developing lung 
(Epstein & Farrell, 1975; v. Golde, 1976). 
2.3.3. Mechanism of surfactant formation 
The type II pneumocytes are responsible for the synthesis of the 
surfactant. They synthesize the phospholipids; in general approx-
imately 90S of the lecithin formed by the choline incorporation 
pathway has unsaturated fatty acids in the C2 position. Although 
such lecithin is less active it plays an important role in pre-
venting collapse of lung alveoli after expiration in premature 
infants. The most active lecithin, dipalmitoyl phosphatidylcho-
line, is formed by the phospholipase reacylation cycle. 
Surfactant contains lipids, carbohydrates and proteins. The lipid 
fraction forms 90S of this mixture and the greater part (90S) ex-
ists as phosphatidylcholine (= lecithin); but phosphatidylglyce-
rol is also present. The surface-active substances (lamellar bo-
dies) are stored in the osmiophylic inclusion bodies in the pneu-
mocytes. By expulsion of these bodies into the alveolar spaces 
the surfactant is activated. A transformation takes place and the 
surfactant changes into tubular myelin. This film covers the al-
veoli and prevents the collapse of the lung alveoli after expira-
tion . 
The exact half-life of the surface-active phospholipids is un-
known but it is removed within 24 to 48 hours depending on gesta-
tional age and composition of the surfactant at that time. 
Spitzer 4 Norman (1971) studied the turnover of surfactant in 
rat lungs. They found that the biological half lives of radiola-
belled choline, leucine and phosphate incorporated into surfac-
tant was 4 5 + 1 hours. This finding supports the concept that 
surfactant is a protein-1ipid complex that turns over as a single 
uni t. 
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3. THE RESPIRATORY DISTRESS SYNDROME 
Respiratory distress syndrome (RDS) is one of the most frequent 
causes of neonatal morbidity and mortality. The overall inci­
dence is 1 - 2S of all live births (Coulter, 1980), but in pre­
term babies the incidence is significantly higher. The data from 
the literature vary, depending on the criteria used for the diag­
nosis of RDS. Tables III.la and III.lb show some data on the in­
cidence of RDS in relation to the menstrual age and the birth 
weight respectively. 
Table III.la. Morbidity due to RDS (%) in relation to the menstrual age 
Weeks (MA): 26 27 2B 29 30 31 32 33 34 35 36 37 38 39 40 Authors (year) 
с SOS <з
 B a d a e t a l # (1977) 
> 573; <! Bauer et al. (1974) 
t 5 7 й _ _ < Berkowitz et a l . (1976) 
t> 54Ж < Chiswick ά Burnard (1973) 
>-52?S < >-19S < C"lSS--< > 0 . 1 S < Jones et a l . (1975) 
>_ 64Й < Richardson et a l . (1973) 
і>-63й--а >-29!S - - < >-3!S a Stinson et a l . (1977) 
t>- ¿0%
 < T h i b e a u l t 4 
Emmanou i l l i des (1977) 
> - - 6 4 . 3 й - 3 5 й - -20.5Й-5.4Й -0.858 — 0 . 0 5 Й Usher e t a l . (1971) 
10058- 68Й 60% 75Í8 3556 20«- « Varner 4 Galask (1981) 
e 24.6% < Yoon 4 Harper (1973) 
Table I I I . I b . I nc idence o f RDS r e l a t e d t o the b i r t h we igh t 
B i r t h we igh t RDS (%) References 
< 2 5 0 0 gram 10-16% Gai rdner ( 1965 ) ; M i l l e r 4 F u t r a k u l ( 1968 ) ; 
Smith (1965 ) ; Usher e t a l . (1964) 
1000-2500 gram 4.7% Amie l -T i son e t a l . (1981) 
< 2000 gram 30% Perk ins (1981) 
> 2 5 0 0 gram 0.05% Amie l -T i son e t a l . (1981) 
N e o n a t e s s u f f e r i n g f r o m RDS show c l i n i c a l s y m p t o m s w h i c h g r a d u a l -
l y I n c r e a s e i n s e v e r i t y . I n e x t r e m e p r e m a t u r i t y o r i f a s p h y x i a 
o c c u r s , r e s p i r a t o r y i n s u f f i c i e n c y may be p r e s e n t a t b i r t h . O t h e r -
w i s e t h e c l i n i c a l p i c t u r e d e v e l o p s w i t h i n t h e f i r s t h o u r s a f t e r 
b i r t h . A n e o n a t e b r e a t h i n g n o r m a l l y d u r i n g t h e f i r s t s i x t o e i g h t 
h o u r s w i l l h a r d l y e v e r d e v e l o p RDS. N e o n a t e s who d e v e l o p RDS show 
an e l e v a t e d r e s p i r a t o r y - r a t e , g r u n t i n g d u r i n g e x p i r a t i o n a n d r e -
t r a c t i o n s o f t h e s o f t t i s s u e s d u r i n g i n s p i r a t i o n . (A u s e f u l s y s -
tem o f g r a d i n g t h e s e v e n t y o f t h e r e t r a c t i o n s was d e v i s e d by 
S i l v e r m a n A A n d e r s o n ( 1 9 5 6 ) ) . H a r s h b r e a t h s o u n d s a r e t h e r u l e , 
and n c r a s t o n a l l y f i n e r a l e s a r e p r e s e n t , e s p e c i a l l y a t t h e e n d o f 
d e e p i n s p i r a t i o n ( A v e r y e t a l . , 1 9 8 1 ) . 
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In severely affected infants there is always cyanosis. Both 
right-to-left and left-to-riqht shunts through the foramen ovale 
and ductus arteriosis .may exist during RDS. Stahlman et al. 
(1972) found that about half the infants with clinical and radio­
logic findings, typical of hyaline membrane disease, had large 
right-to-left shunts within 13 hours after birth; only 15 percent 
had large left-to-right shunts at that time. Closure of the duc­
tus arteriosis із delayed in preterm babies (Daniels, 1 9 8 2 ) . A 
significant left-to-riqht shunt through a patent ductus arterio­
sis contributes to impairment of oxygenation and carbon-dioxide 
elimination. 
Death due to RDS occurs nearly always before 72 hours of age if 
no therapeutic measures are taken. Post mortem examination re­
veals an airless, red-purple and liver-like lunq. On histological 
examination the most striking finding is atelectasis. Eosinophi­
lic membranes adjacent to the aerated portions of the lung are 
only seen if the infant has lived for more than a few hours. 
The radiological findings in these cases are well defined: some 
stages are distinguishable depending on the severity of the di­
sease: fine miliary mottling, a coalescent opacity, increased 
confluence of density with or without an air bronchoqram. Marked 
reticulogranularity and reduced lung field volumes indicate a 
poor prognosis. 
Prevention of RDS is possible by preventinq preterm delivery. 
Several authors advocate the use of drugs to accelerate lung ma­
turation (see chapter 5 ) . Despite all efforts RDS still occurs 
occasionally and dependinq on its severity, a variety of thera­
peutic measures are available. In less severe cases, in which no 
artificial ventilation is required, continuous positive airway 
pressure by endotracheal tube or by nasal cannula can be used. 
Otherwise, intermittent positive pressure ventilation with posi­
tive end expiratory pressure is applied (Chernick, 1974). Treat-
ment of expiratory insufficiency with drugs (e.g. Ambroxol ) or 
artificial surfactant (see chapter 6) has also been proposed by 
several investigators. 
Although surfactant deficiency plays a major role in the develop­
ment of RDS, hypoxia and other factors are also of importance in 
its occurrence in preterm babies (Reynolds et al., 1965; Merrit 4 
Ferrei, 1 9 7 6 ) . Hypothermia can promote RDS by inhihitinq the me-
thylation pathway of the lecithin synthesis. (This pathway is 
chiefly responsible for the production of lecithin before the 
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34th week (MA)). 
Gluck et al. (1972) reported that the surfactant-composition о 
neonates developing RDS was different from surfactant under nor 
mal conditions. There was for instance: 
- reduction in the amount of acetone-precipitable lecithin i 
tracheal aspirates 
- a reduced amount of PDME (PhospatidyIdimethylethanolamine) i 
these aspirates 
- a change in the fatty acid composition of the lecithin. 
Various factors are positively correlated with the risk of deve 
lopinq RDS (table III.II) whereas other factors are believed t 
protect against RDS (table III.III). 
Table III.II. Factors positively correlated with the risk of 
developing RDS 
- prematurity 
- perinatal asphyxia/hypothermia 
- abdominal delivery without labor 
- second twin 
- diabetes mellitus 
- male sex 
Table III.III. Factors negatively correlated with the risk of 
developing RDS 
- premature rupture of the membranes 
- intrauterine growth retardation 
- (pre)eclampsia 
- partial abruptio placentae 
- heroin addiction 
- beta adrenergic drugs, corticosteroids, thyroxine, aminophyl 
lin, Ambroxol® 
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A. FETAL PULMONARY MATURITY 
Maturity can be defined as the condition in which the newborn is 
capable of sustaining vital functions without any help from out­
side. Lung maturity is only one of the important conditions for 
survival of the newborn. 
In normal pregnancies the development of morphological and physi­
ological processes runs parallel. However, in complicated preg­
nancies the sequence of these processes might be different 
(Strassner 4 Nochimson, 1982). A correlation between accelerated 
lung maturity and accelerated neurological maturity exists in 
chronically stressed pregnancies (Gould et al., 1977). 
4.1. Determination of fetal lung maturity 
In preterm neonates the ability to survive is especially determi­
ned by pulmonary function. Some of the maturity tests determine 
specific characteristics of the fetal pulmonary system (lecithin 
content, L/S ratio, shake test, lamellar body phospholipid con­
tent, e t c . ) . Others may be considered to be non-specific; they 
evaluate variables not directly related to the amount of surfac­
tant (e.g. amylase concentration, percentage of lipid positive 
material in amniotic fluid cells, the optical density at 650 n m ) . 
4.2. The L/S ratio 
In 1971 Gluck and associates introduced the lecithin/sphingomye-
lin ratio (L/S ratio) as a diagnostic test for predicting prena-
tally whether the neonate would suffer from RDS. Lecithin is one 
of the most important surface-active substances and it has been 
shown that its level alone may already be a reliable measure of 
estimating fetal lung maturity (Bhagwanani et al., 1972). However 
the concentration in amniotic fluid is subject to alterations due 
to volume fluctuations. The advantage of using a ratio is of 
course its independence of such changes. The sphingomyelin arises 
from different sources. It is an ubiguitous phospholipid which is 
present in most animal tissues and cellular membranes (Rouser et 
al., 196Θ). During the course of gestation its concentration In 
amniotic fluid is relatively stable (Gluck et al., 1971). 
Since the first publication on the L/5 ratio of amniotic fluid in 
1971 by Gluck et al., the test has become popular for the deter­
mination of fetal lung maturity. A mature L/S ratio is however, 
still associated with RDS in about 3 per cent of all cases. This 
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may be due to a reduced sphingomyelin level (Gebhardt, 1982). To 
improve the diagnostic value further investigations have been 
performed and these have led to the determination of the total 
lung profile (see chapter 8 ) . 
It is important to know whether vaginally collected amniotic flu-
id can be used for L/S ratio determinations. There is no agree-
ment in the literature concerning this problem. Possible distur-
bances are: (1) the dilution of amniotic fluid by vaginal secre-
tions, (2) the presence of blood or meconium, (3) contamination 
by semen, (4) uncertain effects of vaginal epithelium or other 
substances. Breech presentation of the fetus may also influence 
the L/S ratio (Worthington 4 Smith, 1978). 
Dombroski et al. (1981) in their combined study of 27 vaginal and 
abdominal samples in term pregnancies concluded that the L/S ra-
tio of vaginally collected amniotic fluid was unreliable. Brame & 
MacKenna (1983) could not confirm this result. From both studies 
it followed that the lung profile was more useful (especially PG 
identification) in vaginal samples. Römern et al. (1984) found 
that seminal ejaculate was rich in sphingomyelin, relatively low 
in acetone precipitatale lecithin and deficient in PG. Thus semen 
contamination lowers the L/S ratio but has no effect on the PG 
content. 
4.3. Other methods for the estimation of lung maturity 
Many other tests have been developed to replace the L/S ratio be-
cause it is time-consuming and can only be performed by well-gua-
lified technicians. There is much to be said for a simpler test 
with a higher sensitivity, specificity and predictive value. The 
two-by-two matrix of diagnostic test results is given in appendix 
1. 
4.3.1. Bubble-test 
The bubble-test (Clements-test) is a rapid, cheap and simple 
test. Different dilutions of amniotic fluid and saline 0.9% are 
made and mixed with 1 ml 958 ethanol. The test tubes are shaken 
for 15 seconds and the presence of bubbles is determined after 15 
minutes. If this test is positive in a dilution of 1 : 2 or more 
the fetal lung is considered to be mature (Whitfield, 1973; Caspi 
et al., 1975; Szabó et al., 1977; Geyer 4 Klosa, 1978; Gusdon 4 
Herbst, 1978; Morrison et al., 1978; Müller-Tyl 4 Salzer, 1978a). 
The predictive value of the bubble test is low. The percentages 
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of false immature results in different studies varies and can be 
as high as 60%. Besides, Thibeault 4 Hobel (1974) observed in so­
me of their patients RDS while the bubble-test was positive, es­
pecially in preterm neonates (gestational age egual to or less 
than 34 weeks) with a 5 minute Apgar score of less than 5. It is 
probable that in these neonates RDS is not primarily due to a 
shortage of surfactant but due to hypoxaemia (Martin et al., 
1974; Veder et al., 1979; Schmidt-Sommerfeld et al., 19Θ2). 
4.3.2. Foam stability index 
A similar test has been published by Sher et al. (197Θ, 1979). 
They correlated lung maturity to the so-called foam stability in­
dex (F.S.I.). They found no RDS if the index was more than 0.47. 
If the index was less than 0.45 the freguency of RDS was 66%. It 
is still unknown if the test is useful in all pregnancies or only 
in those which are uncomplicated. It has been found that biliru­
bin contamination of amniotic fluid depresses the stability of 
foam generated in the FSI-test (DiRocco 4 Golde, 19B3). A commer­
cial version of the manual foam stability index test was evalua­
ted by Lipshltz et al. (19Θ3). They showed that this test was ac­
curate, guantitative and rapid for measuring lung maturity. 
4.3.3. Tap test 
Another comparable test is the tap test in which 1 ml of amniotic 
fluid is mixed with 1 drop of 6N hydrochloric acid and 1.5 ml of 
diethyl ether. The tube is briskly tapped and if no more than fi­
ve bubbles persist in the ether layer after 5 minutes the fetal 
lung is considered mature (Socol et al., 1984). 
4.3.4. Fluorescence polarization 
For this test amniotic fluid has to be incubated with 1,6-diphe-
ny1-1,3,5-hexatriene. It is known that the fluorescence polariza­
tion value is inversely proportional to the degree of fetal lung 
maturity; however different threshold values are reported in the 
literature (Shinitzky et al., 1976; Dledrich et al., 1978a; Elrad 
et al.,1978; Golde et al., 1979; Barkai et al., 1982). 
4.3.5. Optical density 
Sbarra et al. (1977) published a paper on the optical density at 
650 nm (0D650) a n d established that it correlated well with the 
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L/S ratio. After centrifuqation of the amniotic fluid sample at 
3200 rpm (2000g) for 10 minutes the absorbance of the supernatant 
is measured in a cuvette with a 1 cm light path against distilled 
water at 650 nm. They found a critical value of 0.15, which was 
equivalent to an L/S ratio of 2.0. The greatest use of the opti­
cal density measurement may be for samples with either low absor­
bance ( < 0 . 1 0 ) or high absorbance ( > 0 . 2 0 ) as suggested by Tsai 
et el. (1983). 
4.3.6. Surface tension 
Surface tension can be measured directly by using the Wilhelmy 
surface balance. It measures the surface tension while the surfa­
ce is rhythmically compressed and expanded from 100% to 20Й of 
the initial area. Müller-Tyl et al. (1975, 1977, 197B) have shown 
that this test Is clinically useful and that there is also a clo-
se correlation with the L/S ratio (r = - 0 . 8 2 ) . 
4.3.7. Total ph 
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4.3.8. Total lecithin content 
Another biochemical test is the 
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re done by Nelson 4 Lawson (1975 
ргесір i tat ion. 
4.3.9. Amylase concentration 
The amylase concentration determination was introduced by 
Fernandez de Castro et al. (1973) and de Grandi et al. (1979).We 
have performed a comparative study between the amylase concentra­
tion and various other parameters (Feijen et el., 1983). We con­
cluded that there was a positive correlation with the duration of 
pregnancy and fetal weiqht. There was also a significant correla­
tion with the L/S ratio, but the high proportion of false low 
determination of the total leci-
1973). The same measurements we-
); however after previous aceton-
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predictions made the amylase test unsuitable as a screening-teat 
for the measurement of the L/5 ratio (see chapter 9 ) . 
4.3.10« Lamellar body phospholipid content 
A promising test for fetal lung maturation is the lamellar body 
phospholipid content of amniotic fluid. It is a simple, less ti-
me-consuming test which needs very little amniotic fluid 
(Duck-Chong, 1979). Oulton et al. (1980) showed that it is possi-
ble to analyse the various phospholipids in a pellet consisting 
mainly of lamellar bodies. This pellet was isolated after centri-
fugation at 10.000g and removal of the supernatant. However, un-
til now this method is mostly related to the one-dimensional L/S 
ratio (Gebhardt et al., 1982; Egberts et al. 1983); more clinical 
trials In which the values should be related to the neonatal out-
come have to be performed to prove the validity of this test 
(Duck-Chong et al., 1980; Bent et al., 1981; Bent et al., 1982; 
Oulton et al., 1982). 
In the future this test may become the method of choice. 
A review of some of the tests used for evaluation of fetal lung 
maturation is given in table IV.II. Their prognostic values are 
shown in table IV.III. 
Table IV.II. Some tests used for determination of fetal lung maturity 
Test Threshold value (authors, year) 
Foam test 
Foam stability index 
Tap test 
Fluorescence polarization 
Optical density at 650 nm 
Surface tension 
Total phospholipid content 
Total lecithin content 
Total precipitated lecithin 
Lecithin concentration (enzymatic) 
Palmitic acid 
Palmitic/stearic acid ratio 
L/S ratio 
Total lung profile 
Lamellar body phospholipid content 
1 : 2 (Clements et al., 1972) 
0.47 (Sher et al., 1978) 
5 bubbles at 5 minutes (Socol et al., 1984) 
0.316 (Вагкаі et al., 1982) 
0.15 (Sbarra et al., 1976) 
min. 30 dynes/cm (Miiller-Tyl 4 Lempert, 1975) 
2.8 mq% (Schreyer et al., 1974) 
35 mg/1 (Bhagwanani et al., 1973) 
25 mg/1 (Nelson 4 Lawson, 1975) 
5.1 mg« (Diedrich et al., 1979) 
9 mg/1 (Doran et al., 1979) 
3.7 (Doran et al., 1979) 
2.0 (Gluck et al., 1971) 
L/S 2.0 and PG present (Hallman et al., 1976) 
35 mg/1 (Duck-Chong et al., 1980) 
Table IV.III. Value of some tests for the determination of fetal lung maturation 
Test (authors, year) 
Foam test (Schlueter et al., 1979) 
Foam Stability index (Sher et al., 1981) 
Tap test (Socol et el., 1984) 
Fluorescence polarization (Diedrich et al., 1978a) 
Surface tension (Müller-Tyl 4 Lempert, 1975) 
Total Lecithin content (Turnbull et al., 1974) 
Aceton precipitated lecithin (Nelson 4 Lawson, 1975) 
L/S ratio (Gluck 4 Kulovich, 1973) 
Total lung profile (Kulovich et al., 1979) 
Lamellar body phospholipid content (Duck-Chung et al. 
Predictive value (%) 
RDS no RDS 
31 99.5 
30 100 
53 100 
87 98 
65 100 
96 100 
29 99.5 
96 100 
90 100 
1980) 68 99.5 
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5. ACCELERATION OF FETAL LUNG MATURATION 
Various investigations have led to the idea that some drugs can 
accelerate production or release of surfactant. Most publications 
are concerned with corticosteroids, but also other drugs have 
been investigated (e.g. thyroxine, aminophyllin, Ambroxol^). The 
possibility that beta adrenergic drugs stimulate lung maturation 
is discussed in the literature. 
Also a number of maternal diseases are supposed to accelerate fe-
tal lung maturation (Table V . l . ) . 
Table V.l. Factors accelerating maturation of the fetal lung 
(Gluck, 1978) 
Hypertensive syndrome 
Heroin/morphine addiction 
Hemoglobinopathy (Sickle -c) 
Diabetes mellitus (D,F,R) 
Hyperthyroidism 
Maternal infections 
Donor parabiotic twin 
Placental Insufficiency (infarction) 
Chronic retroplacental bleeding (Chronic abruptio placenta) 
Prolonged rupture of the membranes 
5.1. Corticosteroids 
In the seventies some investigators showed that the fetal lungs 
of different species have specific glucocorticoid receptors 
(Ballard 4 Ballard, 1972; Toft 4 Chytil, 1973; Ballard 4 Ballard, 
1974; Giannopoulos, 1974). 
Musson (1968) already found a decreased incidence of RDS in hu-
mans when he gave hydrocortison preoperati vely (cesarean sec-
tions) . 
The results of the first animal experiments were published by 
Moog 4 Richardson (1953, 1955) and Buckingham et al. (1968). Moog 
4 Richardson (1955) found an increase in gut alkaline-phosphatase 
activity in mice and chickens; Buckingham et al. (1968) saw an 
increase in lung differentiation in rabbits. (Both gut and lung 
originate from the entoderm and their development runs parallel.) 
Liggins published in 1969 his study on accelerated lung maturity 
in sheep after glucocorticoid medication. While he was studying 
the effect of glucocorticoids on parturition, he noted that the 
lungs of lambs delivered prematurely after dexamethason infusions 
in utero were partially aerated. This did not occur prior to the 
125th day of pregnancy (normal duration of pregnancy is 1*7 
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days). After intrauterine administration of corticosteroids, suf-
ficient lung maturation was seen from the 118th day onward. 
Anderson et al. (1981) compared the effect of dexamethasone, be-
tamethasone and prednisolone on lung development in the rat and 
found that betamethasone was the most potent drug for promoting 
maturation. 
Delemos et al. (1970) studied twin-pregnancies in sheep. In one 
of the amniotic sacs they injected corticosteroids; the other 
served as a control. Sixteen hours to three days after starting 
this therapy there was a lower minimal surface tension and more 
air-retention after expansion and deflation in the fetus treated 
with corticosteroids. 
In rabbits Motoyama et al. (1971) saw an increase of type II 
pneumocytes after corticosteroid-therapy. Besides, the osmiophy-
lic inclusion bodies were seen earlier, indicating surfactant 
production. Many more papers have recently been published on this 
subject. 
Naeye et al. (1971) concluded from autopsies of 387 neonates, 
who died from ROS, that the adrenal qlands were lighter (19S) and 
that the amount of cortical cells was reduced. Besides in anence-
phalics they found a decreased amount of osmiophylic inclusion 
bodies in the type II pneumocytes (45S of the amount in control 
infanta). Baden et al. (1972) and Reynolds (1973) observed that 
neonates suffering from RDS had higher plasma Cortisol levels. 
This indicated a relative depletion of endogenous corticosteroids 
which was compensated by a higher adrenal response. Murphy et 
al. (1974),Fencl 4 Tulchinsky (1975), Tan et al. (1976) and Smith 
et al. (1977) found an increased Cortisol level in amniotic fluid 
in relation to increased gestational age. In the beginning of 
pregnancy there was a slow increase with a plateau between the 
20th and the 37th week (MA); thereafter there was a rapid rise 
until term. However, low corticosteroid levels were not implica-
ted in the pathogenesis of RDS (Kenny et al., 1973). In 4 chil-
dren with familiar aplasia of the adrenal glands they observed no 
RDS. 
Table V. 11. gives a review of the literature concerning the ef-
fects of corticosteroids on the incidence of RDS. Only those 
trials which were double-blind and randomized are shown. It was 
observed that in most studies some kind of tocolytic drug was al-
so administered; only Spellacy et al. (1973), Ekelund et al. 
(1976) and Morrison et al. (1980) do not mention if tocolytic 
Table V.II. Effects of corticosteroid medication on the incidence of RDS in double-blind randomized 
trials (review from the literature). 
Author(s) (year) Drug (dose) Menstr.age (weeks) Effect 
Block et al.* 
(1977) 
Block et al.* 
(1977) 
Collab. study group* 
(1981) 
Doran et al.* 
(1980) 
Ekelund et al. 
(1976) 
Farrell et al.* 
(1983) 
Liggins (1976)* 
Morrison et al. 
1980) 
Papageorqiou et al.* 
(1979) 
Schmidt et al.* 
(1984) 
Schutte et al.* 
(1980) 
Spel lacy et al. 
(1973) 
Betamethasone 
(24 mg/48 hours i.m.) 
Methylprednisolone 
(125 mg/48 hours i.m.) 
Dexamethasone 
(20mg/48 hours i.m.) 
Betamethasone 
(24 mg/48 hours i.m.) 
Betamethasone 
(36 mg/72 hours i.m.) 
Dexamethasone 
(20 mg/48 hours i.m.) 
Betamethasone 
(24 mg/48 hours i.m.) 
Hydrocortisone 
(2 gr/48 hours i.m.) 
Betamethasone 
(24 mq/48 hours i.m.) 
weekly repeated) 
Betamethasone 
(24 mg/48 hours i.m.) 
Betamethasone 
(28 mg/4B hours i.m.) 
Dexamethasone 
(2 gr. daily/2 weeks p.о.) 
< 3 7 
<37 
26-37 
24-34 
29-36 
26-34 
<34 
26-35 
25-34 
26-32 
26-32 
28-32 
Reduced incidence 
of RDS (p <.05) 
No difference 
Reduced incidence 
of RDS (p = .05) 
Reduced incidence 
of RDS (p<.05) 
Increased L/S ratio 
Reduced incidence 
of RDS (p= .30) 
Reduced incidence of RDS (p= .04) 
Reduced incidence of RDS 
Increased L/S ratio (p<.001) 
Reduced incidence 
of RDS (p<.005) 
Reduced incidence of 
severe RDS (p= .038) 
Reduced incidence of RDS (not 
significant) 
Increased L/S ratio 
In these studies also beta adrenergic drugs were administered 
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drugs were used. 
Recently a multicentre double-blind, randomized trial was perfor­
med with 690 women between 26 and 37 weeks of gestation. A diffe­
rent overall incidence of RDS was found (1 Й vs. 12,6%; p < . 0 0 1 ) . 
The positive effect was, however, restricted to singleton female 
infants (p <.001) (Collaborative group on antenatal steroid the­
rapy, 1 9 Θ 1 ) . Approximately 50$ of the patients were also treated 
with beta adrenergic drugs. In this study the fetal condition at 
birth was not taken into account (e.g. pH umbilical artery or Ap­
gar score). The suggestion that male infants are more susceptible 
to RDS could not be proven in the study of Leveno et al. (1984) 
with twin gestations. 
Negative effects of corticosteroid treatment have also been ob­
served. Johnson et al. (1979) and Novy 4 Walsh (19Θ3) described 
mul tisystemic changes in rhesus monkeys after corticosteroid 
treatment (the daily doses used were comparable to those recom­
mended in humans). 
The following effects were seen: a reduction in fetal head cir­
cumference, thymus weight, adrenal weight, spleen weight, fetal 
growth A placental weight and an increase in fetal liver weight. 
Until now such negative effects have not been reported for the 
human after treatment with corticosteroids. However, in combina­
tion with beta adrenergic drugs, maternal mortality has been ob­
served (see chapter 5 . 2 . ) . 
According to Sachs (19B1) the potential adverse effects of the 
use of corticosteroids in pregnancy are: 
- Suppression of maternal and fetal adrenal cortex function 
- Decreased maternal urinary oestriol excretion 
- Increased insulin requirements in pregnant diabetics 
- Increased risk of fetal death in severe toxemia 
- Altered maternal leucocyte profile 
- Increased perinatal infection rate 
- Potential neurological hazards 
- Premature maturation of fetal biochemical processes in 
other organs 
- Risk of neonatal hypoglycemia 
- Altered fetal thyroid function: significantly increased le­
vels of Τ 3 and гТЗ in umbilical plasma. 
Different speculations have been forthcoming about the physiolo­
gic altprations caused by corticosteroid treatment. 
Гаггеіі (1977) reported accelerated lung maturation as measured 
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by lung lecithin concentration, increased alveolar deFlation sta­
bility, increased lunq distention and morphologic changes. Howe­
ver, Beck et el. ( 1 9 8 1 B ) only showed an increase in total lung 
volume; lunq surfactant properties remained unchanged. The corti-
costeroid-induced hyperlnsulinemia did not prevent the increase 
in maximum lung volume. 
The alterations after corticosteroid treatment could be caused 
by: 
- an increase in the amount of cholinephosphotransferase, an en­
zyme that is known to be a limiting factor in the lecithin syn­
thesis (Farrell et al., 1977), 
- an inhibition of phosphodiesterase, which leads to an increase 
in cyclic AMP and by that way to an increase in surfactant 
(Liu, 1973), (Other drugs such as thyroxine, aminophyllin and 
beta adrenergic drugs are thought to have the same influence.) 
- a direct effect via beta adrenergic receptors (Jacobs et al. 
19Θ3), 
- a direct effect on connective tissue without changes in lung 
surfactant properties (Beck et al. 1981b). 
Repeated amniocentesis for monitoring the effect of corticoste­
roid therapy is not advisable (Farrell et al., 1983). Table 
V.III. gives a review of the literature concerning the effect of 
corticosteroid medication on the L/S ratio. 
Table V.III. Effect of the corticosteriod medication on the L/S 
ratio. 
Author(s) (year) 
Liggins & Howie* 
Caspi et al. 
Spellacy et al. 
Fargier et al.* 
Kennedy 
Bureau et al. 
Caspi et al.* 
Ekelund et al. 
Liggins* 
Panter-Brick 
Caritis et al. 
Zuspan et al.* 
Diedrich et al. 
Nagy et al. 
Szabó et al.* 
Arias et al. 
Morrison et al. 
Farrell et al. 
* In these studie 
1972) 
1973) 
1973) 
1974) 
1974) 
1975) 
1976) 
1976) 
1976) 
1976) 
1977) 
1977) 
1978b) 
1978) 
1978) 
1979) 
1980) 
1983) 
ÍS also 
CortIcosteroid 
Betamethasone 
Dexamethasone 
Dexame thasone 
Bet ame thasone 
Betamethasone 
Betamethasone 
Dexamethasone 
Betamethasone 
Betamethasone 
Dexamethasone 
Betame thasone 
Hydrocort isone 
Betamethasone 
Dexame thasone 
Predni solone 
Betamethasone 
Hydrocort1sone 
Dexamethasone 
beta adrenergic 
Route 
Int ramuscular 
Int ramuscular 
Oral 
Intravenous 
Intramuscular 
Int ramuscular 
Intramuscular 
Intramuscular 
Int ramuscular 
Intravenous 
Int ramuscular 
I η t ravenous 
I ηt ramuscular 
Intravenous 
Int ramuscular 
Int ramuscular 
Intravenous 
Int ramuscular 
L/S ratio 
Unchanged 
Increased 
Increased 
Unchanged 
Unchanged 
Unchanged 
Increased 
Increased 
Unchanged 
Increased 
Unchanged 
Increased 
Increased 
Increased 
Ine reaseri 
Increased 
Increased 
Unchanged 
drugs were administered. 
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As a result of these studies (table V. 11. 4 V.I I I . ) , corticoste-
roid treatment could be considered useful if: 
- the menstrual age is less than 35 weeks, 
- the extent of lung maturity is unknown, 
- delivery is not expected within at least 24 hours (the half-li-
fe of surfactant is about 14 hours. Tierney et al., 1967), 
- there are no contraindications for short term corticosteroid 
administ ration. 
However, prolongation of the menstrual age until the 35th week 
probably deserves priority above treatment with corticosteroids. 
5.2. Beta adrenergic drugs 
During the last 15 years beta adrenergic drugs have been introdu-
ced into obstetrics to inhibit premature contractions and to pre-
vent early labor (Hendricks et al., 1961). Until now these drugs 
have especially been used in Europe. Also acute fetal asphyxia 
due to uterine contractions is treated with beta adrenergic drugs 
(Caldeyro-Barcia et al., 1969; Esteban-Altirriba et al.,1972; 
Castren et al., 1972). 
The effect of beta adrenergic drugs on lunq maturation during 
long term administration is still uncertain. In double-blind pla-
cebo controlled studies in humans there was a positive effect 
(Wesselius-de Casparis et al., 1971; Castren et al., 1972; Cabero 
et al., 1979). 
Bergman 4 Hedner (1978) and Cabero et al. (1979) reported a posi-
tive influence regarding the decreased RDS-incidence. A study 
group was compared to an "advanced premature labour" group of the 
same gestational age. 
Papers which do not support these findings were published by 
Dudenhausen et al. (1978) and Goeschen et al. (1980). The former 
saw a decrease in lecithin concentration after fenoterol medica-
tion after the 33rd week of pregnancy. Nothing was mentioned 
about the incidence of RDS. 
Many investigators have studied the effect on lunq development in 
rabbits (Wyszogrodski et al. 1974; Cabero et al., 1977; Bergman 
et al., 1978; Bergman et al., 1979; Enhorning, 1979; Lipshitz et 
al., 1981). All studies showed a positive effect on lunq matura-
tion and function. However, Ekelund et al. (1983) showed that in-
tense or long-lasting therapy with terbutaline depletes surfac-
tant stores which may lead to a surfactant deficiency in the al-
veolar space. 
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Rudolph (1977) saw an increase in adrenal blood flow after n t o -
d n n e infusion to the mother. Infusion to the fetus made the pul-
monary vessels less susceptible to acetylcholine and the vasodi-
latation was reduced. The experiments were done in sheep using 
the microsphere technique. Beck et al. (1983) stated that in fe-
tuses of the rhesus monkey, beta adrenergic drugs stimulate the 
surfactant release from type II cells into the alveolar spaces. 
Many theories have been suggested about the mechanism responsible 
for this positive effect. Dawes (1968) reported that there was an 
increase in lung perfusion in sheep. Castren et al. (1972) sug-
gested a strong dilatation of lung vessels and a positive influ-
ence on the sympathie nervous system of the fetus. 
Kero et al.(1973) suggested an improvement in the oxygen trans-
port probably caused by a weak alpha-lytic and spasmolytic action 
resulting in a dilatation of the lower airways. 
Wyszogrodski et al. (1974) thought that there was an increased 
expulsion of lung surfactant in the alveolar space and Gamissans 
et al.(1974) reported an improvement of fetal pH and oxygen satu-
ration. 
Weiss 4 Puqh (1976) cited earlier theories; there could be a re-
lease of ACTH (Vogt, 1948; Vernikos-Danel 1 is 4 Marks, 1962) and/ 
or a direct influence on steroid production in the fetal adrenal 
gland (Cooper 4 Rosenthal, 1962). Both actions led to an increase 
of the corticosteroid level (the influence on the steroid genesis 
in the cortex of the adrenal gland has also been reported by Liu 
in 1973). 
Vigilance is required if beta adrenergic drugs are used, es-
pecially in combination with corticosteroids. Maternal morbidity 
and even mortality has been described (Bender et al., 1977 
Kubli, 1977; Flliott et al., 1978; Donatha et al., 1978 
Stubbefield, 1978; Babenerd 4 Flehr, 1979; Roqqp et al., 1979 
Tinga 4 Aarnoudse, 1979; Wolff et al., 1979; Eskes et al., 1980 
Grospietsch et al., 1980; Milllez et al., 1980; Evron et al., 
1983; Semchyshyn et al., 1983). 
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5.3. Thyroxine 
Thyroxine is one of the hormones which may be involved in the ma-
turation of the fetal lung. In studies on thyroxine administra-
tion to rats or rabbits the following effects have been observed: 
- an increased number of lamellar bodies in the alveolar type II 
cells (Wu et al., 1973). 
- an increased amount of phosphatidylcholine in lung lavages 
(Rooney 4 Motoyama, 1977). 
- an increased volume and amount of the type II cells (Redding 
et el., 1972). 
A great disadvantage of this drug is its poor permeability 
through the placenta (Grunbach 4 Werner, 1956; Gross, 1979). How-
ever, Fischbach et al. (1982) reported increased dipalmitoyl le-
cithin contents in the lungs of rat fetuses after direct admini-
stration to the mother. 
In humans this therapy has been tried both during pregnancy 
(Mashiach et al., 1978; Mashiach et al., 1979) and post partum 
(Schönberger et al., 1981). 
The findings of a low concentration of tri-iodothyronine and thy-
roxine in the cord blood of newborn infants with RDS (Cuestas et 
al., 1976) suggest a relationship between thyroxine and fetal 
lung maturation. This relationship was demonstrated later by 
Hitchcock (1979). According to these results the effect of thyro-
xine is more pronounced in the presence of glucocorticoids (less 
effective after adrenalectomy or metopirone medication). 
Since thy rotropiη-release hormone (TRH) crosses the placenta, 
this drug was administered to pregnant rabbits by Rooney et al. 
(1979) who obtained the same promising result. No information is 
available on the effect of this drug on the human. 
5.4. Ambroxol® 
The possibility that the Bromhexine metabolite VIII (Ambroxol^) 
could accelerate lung maturity, was studied by various authors. 
Substances activatinq secretory cells of the tracheal trunc which 
could possibly influence the alveoli have also been investigated. 
After the first optimistic reports (Rufer et al., 1969; v. 
Wiehert 4 Kohl, 1971; Gil 4 Thurnheer, 1971; Curti, 1972; Curti, 
1974; NoacU 4 Eibrecht, 1975; Lachman et al., 1976; ν. Wiehert et 
al., 1977) Gerner 4 Halberstadt (1977), Bauer (1978) and 
Krieqlsteiner et al. (1978) studied the effect of Ambroxol®in 
pregnant mice, rets and rabbits but found no accelerated lung ma-
Table V.IV. Review from the literature dealing with the effect of Ambi 
Model Dose Author(s) 
Curti 
Curti 
Lorenz et al. 
Noack 4 Eibrecht 
Egberts et al. 
Gerner i Halberstadt 
ν. Wiehert et al. 
Bauer 
Finnila et al. 
Kriegisteiner et al. 
Lorenz et al. 
Herkus et a l . 
Müller-Tyl 4 Salzer 
v. Petten et a l . 
Prévost et a l . 
Fîenovanz 4 Keuth 
Zahn et a l . 
ferutti 4 Kapanci 
Kriegisteiner et al. 
Flemer et al. 
Maloney 4 Brodecky 
Year 
1972) Mice 
1974) Mice 
1974) Humans 
29-33 wks. 
1975) Rats 
1976) Sheep 
1977) Rats 
1977) Rabbits 
1978) Mice 
197B) Neonates 
(human) 
1978) Rats 
Rabbits 
1978) Humans 
29-34 wks. 
1978) Humans 
1978b) Humans 
33-34 wks. 
1978) Sheep 
1978) Rabbits 
1978) Neonates 
(human) 
1978) Humans 
28-39 wks. 
1979) Rats 
1979) Rats 
1980) Rats 
1980) Sheep 
40 mg 2dd/5 days p.o. 
0.4 mg intraamniotic 
1 mg/kg І. ./5 days 
30 mg/kg p.o./7-9 days 
5-10 mg/day 
1-10 mg/kg intraperitoneal 
10 mg/kg i.v. 
30 mg/kg i.v./4 days 
p.p. 2 mg/kg intraarterial 
during 5 days 
10 mg intraperitoneal 
100 mg intraperitoneal 
1 mg/kg i.v./4 days 
100-200 mg dd i.v./5 days 
800 mg dd i.v./4 days 
4 mq dd/4 days 
30 mg 2dd intraperitoneal 
during 4 days 
p.p. 3 mg/kg 3dd i.v. 
during 6 days 
800 mg dd i.v./5 days 
200 mq p.o./3 days 
30 mg/kq intraperitoneal 
during 4 days 
200 mq/kg p.o/3 days 
10 mq in fetal jugular vein 
іхоГ^ administration 
Result 
lowering surface tension, increased activity type II cells 
increased amount type II pneumocytes 
increased total phospholipids and lecithin content 
earlier epithelial differentiation and cell-ripening 
increased L/S ratio 
no effect 
stimulation of phospholipid synthesis 
(more marked in short time experiments) 
no effect on lecithin synthesis 
increased L/S ratio after 5 days decreased RDS 
no effect ^ 
no effect 
no effect 
no effect on L/S ratio 
increased L/S ratio, reduced incidence of RDS 
increased L/S ratio 
37Й increase of total phospholipids 
more than 37 wks 4 more than 2300g: positive effect 
increased L/S ratio (33-34 weeks) 
Increased lamellar body volume 
No effect on total phospholipid content or L/5 ratio 
TPL-increase 
increased L/S ratio 
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turity. ν. Petten et al. (1978) found a significant increase of 
L/S ratios in ovine tracheal fluid in long-term cannulated lamb 
(RÏ fetuses after intravenous administration of 4 mg Ambroxol /kg/ 
day. In pregnant rabbits similar results were obtained. The ef-
fect was seen 4 days after its administration. 
In minipigs treatment of the mother may be effective because 
transplacental transport takes place (Endell et el., 1977; Rufer 
4 Busch, 1978). 
Lorenz et al. (1974) saw significant changes in total phospholi-
pid and lecithin concentration as well as In the L/S ratio if hu-
mans were given intravenous injection of Ambroxol between the 
29th and 33rd week (MA) of gestation. The same authors however 
did not see a reduction in RDS in a double-blind clinical trial 
after intravenous medication to the pregnant mother between the 
29th and 34th week (MA) of gestation (1978). 
In β double-blind study Merkus et al. (1978) also did not find a 
(F 
significant rise in the L/S ratio. They administered Ambroxol 
daily for 5 days to women ranging in gestational age from 196 to 
243 days. The patients were simultaneously treated with isoxsu-
prine for premature labor. 
Zahn et al. (1978) found an increased L/S ratio and a decreased 
incidence of RDS after Ambroxol^ treatment (800 mg daily during 5 
days). However, beta adrenergic drugs (Fenoterol) were also admi­
nistered. Müller-Tyl 4 Salzer (1978b) found that if the same dose 
was administered during 4 days without beta adrenergic drug admi-
nistration there was also improvement in lung maturity. 
CR4) 
Postnatal treatment with Ambroxol seems also valuable (Renovanz 
4 Keuth, 1978) after 37 weeks of pregnancy or if a birth weight 
of 2300 grams or higher is reached. Identical results are found 
by Tinniiä et al. (1978). (The incidence of RDS .however, in a 
group of neonates older than 37 weeks is almost zero even without 
treatment.) 
In summary the data from the literature are still controversial 
(a review is given in table V. IV.). Therefore it was decided to 
study the effect of this agent in pregnant monkeys. The results 
are discussed in chapter 10.2. 
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SURFACTANT REPLACEMENT 
Although many attempts have been made to reduce the incidence of 
RDS, the neonatologists are still confronted with this disease. 
Drugs which are in use to prevent RDS ante partum, are less suc­
cessful when given post partum, (e.g. corticosteroids). The basic 
thought behind this treatment seems very simple: RDS is due to a 
shortage of surfactant; thus addition of this surfactant will 
normalize respiration. 
The different types of surfactant in use at present are: 
- natural surfactant 
- artificial surfactant 
- a combination of both 
The first replacement studies were done in the nineteen sixties. 
They were not encouraging because only phosphatidylcholine was 
used and this substance, by itself, does not have the optimal 
surface properties of natural surfactant. 
More recently many studies on replacement of surfactant were pu­
blished; most investigators reported that the fetal lung function 
improved after administration of surfactant to prematurely born 
animals (lambs, rabbits) and humans. 
Very promising results were reported by Fujiwara et al. (1980) 
with their combination of bovine natural surfactant and synthe­
tic phospholipids. This "Fuji-surf", tested in 10 neonates with 
RDS, consisted of: 
56S dipalmitoyllecithin 
21% unsaturated lecithin 
108 phosphatidylglycerol 
6% other phospholipids normally present in lung surfactant 
5% neutrolipids 
2% protein 
Their results were satisfactory: 8 neonates survived; 2 died of 
unrelated causes. 
Obladen et al. (1979a) tested a synthetic phospholipid-mixture 
containing 90S dipalmitoyl lecithin and 10% dipalmitoyl phospha-
tidylglycerol. In trials In which only dipalmitoyl lecithin was 
used, no beneficial effect was observed, possibly because of in-
activation by ultrasound nebulization. However, a nebulized sur­
factant consisting of both dipalmitoyl lecithin and dipalmitoyl 
phosphatidylglycerol was successfully used by Ivey et al. (1976) 
in 6 neonates with RDS. 
39 
Kobayashi et al. (1981) added СаСІ2 to the surfactant of pigs. It 
had been reported that cations bind saturated phospholipids and 
form β more stable surface-film, especially if the concentration 
of surface-active phospholipids is low. Of the two first neonates 
with RDS, treated with this surfactant, one reacted very favoura­
bly whereas the other gave a transient response. 
Metcalfe et al.(1980) did not include protein in the artificial 
surfactant, because proteins are not necessary for lowering the 
surface tension and may give immunological problems. Data from a 
preliminary clinical trial show its efficiency (Smyth et el., 
1981). 
Morley et al. (1981) investigated the beneficial effect of "dry-
surfactant", consisting of dipalmitoyl lecithin and unsaturated 
phosphatldylglycerol in a ratio of 7 : 3. The surfactant-treated 
neonates needed significantly lower mean peak pressures, during 
ventilation in the first 6 hours, to produce good ventilation, 
than the controls ( p < . 0 5 ) . 
Hallman et el. (1981) suggested that the human fetus can be used 
as a donor of homologous surfactant by isolating surfactant from 
amniotic fluid by sucrose-gradient cent rifugation. This natural 
surfactant has been tested successfully in a human infant suffer­
ing from RDS (Hallman et al., 1982a). 
From the results so far, it seems that beneficial effects can be 
obtained with surfactant replacement therapy. There is now need 
of a prospective double-blind clinical trial in neonates, with a 
high risk for developing RDS or with early signs of RDS. 
The guestion remains whether other artificial surfactants should 
also be tested. Such a surfactant should have the following pro­
per ties : 
1. there should be a rapid adsorption at the air-liquid in­
terface at 37'C, 
2. there should be spreading at the air/water interface with 
formation of a monolayer, 
3. it should reduce the surface-tension to nearly zero under 
dynamic conditions, 
4. it should improve pulmonary pressure-volume characteris­
tics and alveolar air expansion in premature neonates, 
5. it should improve lung compliance in ν ivo, 
6. it should prevent RDS and bronchial epithelial lesions. 
However, even if surfactant replacement does not prohibit the on­
set of RDS, it might still be beneficial. With its use the dura-
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tion of intubation and the oxygen-administration could be redu-
ced. These two factors are the most common sequelae of RDS which 
lead to bronchopulmonary dysplasia. 
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7. A STUDY OF THE L/S RATIO IN THE HUMAN 
In the literature the L/S threshold value indicating fetal lung 
maturity is mostly reported as 2.0. However, many studies demon­
strated the incomparability of the L/S ratios from different la­
boratories. In this study the L/S ratios were compared with the 
neonatal outcome with respect to the development of RDS. 
Many data are available on the influence of pregnancy and condi­
tions of labor upon the L/S ratio. Several of these variables 
were investigated in this study and compared with results from 
other publications. 
7.1. Material and methods 
The retrospective study was carried out in 1974-1980 in the De­
partment of Obstetrics and Gynaecology at the University Hospi­
tal, Nijmegen. It consisted of 388 gravidae (562 amniotic fluid 
samples) between the 17th and 44th week (MA). 
The duration of pregnancy was based on: 
a) the menstrual history, 
b) ultrasonography early in pregnancy, 
c) the basal body temperature-curve. 
Cases, In which the determination of the duration of pregnancy 
was inaccurate, were excluded. 
number of L/S ratios 
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The distribution of the number of amniotic fluid samples accor­
ding to the menstrual age is given in figure 7.1.1.The L/S ratio 
was determined according to the method published by Gluck et al. 
(1971) with a slight modification. The steps of the L/S determi­
nation are given in table VII.I. 
The L/S ratio measurements were performed twice weekly directly 
after amniocenteses in the morning. In the evening of the same 
day the results were known. If samples were not assayed immedia­
tely, they were stored at -20'C. 
Table VII.I. Steps involved in the determination of the one di­
mensional L/S ratio. 
1. Extraction of the lipids by adding methano1 :chloroform (1:2) 
2. Precipitation of surface active phospholipids with cold aceto­
ne (-20*C). 
3. Separation of the phospholipids by means of thin-layer chroma­
tography. (An aliguot is spotted on silica gel G and developed 
in chloroform/methanol/water, 65/30/4 (v/v/v)). 
4. After drying in the air, the compounds are identified by 
spraying the plate with H2SQ4 ( Ю оій) and charring (250'C) 
for 5 minutes. 
5. Measuring of the spots by reflectance densitometry (Vitatron 
TLD 100 densitometer) at 49 nm. 
All phospholipid determinations were done in duplicate. 
It is known from the literature that the L/S ratios, determined 
by one-dimensional thin-layer chromatography, depend on: 
- the centri fugation step (speed and duration), 
- the acetone precipitation step, 
- the method of measurement of the spots after visualisation, 
- blood and/or meconium contamination of the sample. 
Therefore it is of utmost importance that each laboratory stan­
dardizes its method and evaluates together with the clinician the 
prognostic value of the test. 
The diagnosis of RDS was made by a pediatrician using the follo­
wing criteria: 
- tachypnea and generalized cyanosis in the absence of oxygen 
therapy, 
- sternal and intercostal retractions, 
- expiratory grunts, 
- abdominal protrusion during inspiration, 
- rales and decreased entry of air into the lungs, 
- radiographic pictures: reticulogranular pattern; airbronchogram. 
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The incidence of RDS in the study-qroup was 4.1Й (15/376) in 
singleton pregnancies and 5.8$ (3/52 children) in twin pregnan­
cies. RDS was only seen before the 36th week of pregnancy. A re­
view of the infants suffering from RDS is given in table VII.II. 
Table VII.II. Review of the infants with RDS 
Pt-number L/S ratio menstrual age at menstrual age birth 
the time of the at the time weight 
amniocentesis of delivery in grams 
in days in days 
β 
9 
52 
67 
68 
100 
105 
124 
221 
227* 
227» 
245 
291 
292* 
365 
379 
400 
405 
1.4 
0.9 
0.7 
1.3 
1.1 
0.5 
1.0 
1.9 
0.6 
1.4 
2.2 
1.1 
0.9 
1.0 
0.5 
0.8 
1.4 
1.2 
203 
235 
192 
229 
220 
222 
216 
231 
231 
224 
224 
248 
210 
218 
213 
211 
226 
225 
251 
235 
192 
232 
224 
222 
216 
231 
231 
224 
224 
249 
211 
218 
222 
211 
226 
225 
1570 
2200 
1100 + 
1780 + 
1120 + 
1800 
1015 + 
1400 
2100 
2210 
1680 
2310 
1060 + 
900 + 
800 + 
10ПП + 
1600 
1810 
* Twin-pregnancy 
+ = died 
An influence of relative centrifugal force on the L/S ratio has 
been described (Cherayil et al., 1977; Oulton, 1979). (This pro­
cedure is necessary to remove fetal cells from the amniotic 
fluid). Reference values for the L/S ratio can not be given with­
out specification of the centrifugal condition (v. Voorst tot 
Voorst, 1980). 
Blood or meconium contamination of the amniotic fluid also influ­
ences the results (Kulkarni et al., 1972; Wagstaff et al., 1974; 
Ruhi 4 Spellacy, 1975). v. Voorst tot Voorst (1980) found that a 
contamination with 0.01% volume of blood or up to 10 g/1 meconium 
was permissible. Blood contamination also influences colour deve­
lopment (the unsaturated lecithin of serum and red blood cells 
stains differently when compared to the staining of lecithin of 
lung surfactant). The use of the phosphomolybdate stain appears 
to prevent false prediction of lung maturity (Cotton 4 Spillman, 
1983). 
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In our laboratory we investigated the influence of the aceton 
precipitation step and blood contamination on the L/S ratio and 
came to the following conclusions: 
- L/S ratios determined without the aceton precipitation step we­
re much higher; 
- If the L/S ratios were below 4.0 aceton precipitation during 5 
minutes at 0"C or during 30 minutes at -20'C did not alter the 
result; 
- If amniotic fluid with an L/S ratio of 0.5-0.6 was adulterated 
with 10Й serum the L/S ratio increased to a value of 1.2-1.4; 
- Adding serum to amniotic fluid with an L/S ratio of 2.2 led to 
a decrease in the L/S ratio to 1.2 (amount of serum added = 
10%) . 
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7.2. Statistical methods 
7.2.1. A statistical model for the changes in the L/S ratio du­
ring gestation. 
L/S ratios in amniotic fluid were grouped over the last 12 weeks 
of pregnancy (29-40 weeks MA). In order to compare the course of 
the L/S ratio during pregnancy in the different groups of pa­
tients, a model subset was created from the collected data. The 
first samples of amniotic fluid of all singleton pregnancies were 
selected for this purpose. We excluded samples from patients 
using drugs such as beta adrenergic drugs, corticosteroids and/or 
methyldopa. Samples derived from pregnancies in which rupture of 
the membranes had occurred more than 24 hours earlier were also 
excluded. 
The mean L/S ratio of all samples and of the model subset with 
their standard deviation for each week between the 29th and 4nth 
week (MA) of pregnancy are given in table V11 . 11 I . 
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Table VII.III. Mean and standard deviation (SD) of the L/S ratio 
as a function of the week of menstrual age for all 
samples and for the model subset. 
MA 
in weeks 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
All samples 
number mean SD 
of 
samples 
4 0.90 0.36 
10 1.24 0.87 
18 1.18 0.65 
29 1.66 1.04 
49 1.63 1.03 
64 2.09 1.41 
83 2.61 1.66 
96 2.78 2.01 
91 3.49 2.34 
51 3.13 1.77 
30 3.30 1.82 
536 
Model subset 
number mean SD 
of 
samples 
2 0.75 0.21 
6 1.27 0.55 
5 1.08 0.86 
9 1.86 1.22 
23 1.40 0.81 
27 2.05 1.40 
38 2.45 1.56 
51 2.82 2.21 
54 3.41 2.15 
33 3.19 1.81 
13 3.87 2.03 
267 
The mean L/S ratio + 2 SEM (standard error of the mean) of the mo­
del subset for the week of menstrual age (weeks) is given graphi­
cally in fig. 7.2. 1. . 
Until the 30st week of pregnancy the L/5 ratio remains almost 
constant (Gluck et al., 1971). Then an exponential-like increase 
is observed. A description of this change can be given by means of 
a two-phase regression model: 
f(L/S) = e
o
 + e , 197 < t < T 0 
f(L/S) = 0
o
 * Θ, (t-T 0) + e , T 0<t <280 
with ε~Ν(0;σ2). 
f(L/S) is a suitable (normalizing, variance stabilizing, lineari­
zing) transformation of the L/S ratio to the form: 
a)fo(L/S)= L/5, without transformation 
b) f ι (L/5)=VL/S, square root transformation 
c)f2(L/S)= In L/S, logarithmic transformation 
The choice of the transformation is based on the correlation co­
efficient (r) between f(L/S) and t, and the ratio of the largest 
and lowest standard deviation (Smax/Smin) between the 33rd and 
40th week of pregnancy. 
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Figure 7.2.1. The mean L/5 ra­
tio + 2 SEM for the menstrual 
age in weeks in the model sub­
set together with the fitted 
two-phase regression 'model 
(number of samples given in 
brackets) 
LIS ratio 
τ—ι—ι—Γ 
2B 30 32 34 36 38 40 
menstrual age in weeks 
period 
2 2 5 < t < 2 8 0 
transformat ion 
L/S VL/S In L/S 
Smax/Smin 
.37 
2.75 
.41 
1.79 
.44 
1.41 
It was decided to modulate the description of the I /S ratio in 
relation to the duration of the menstrual aqe as follows: 
In L/S =θ„ + e , 197 < t < 210 
θ 0 + Д і - г Ш + е , 2io < t < 280 
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This change was introduced because the highest correlation coef-
ficient (0.44) was found after logarithmic transformation and the 
Smax/Smin was closest to 1. 
(For choosing the change-over point at t = 210, see appendix 2 ) . 
In the model: 
e = the variation in the In L/S from amniotic fluid samples of 
the pregnant women of the same menstrual age t(days). The dis-
tribution of € is normal (Gauss) with mean zero and standard 
deviation σ . The coefficient of variation for the L/S ratio at 
menstrual age t is expected to be the same for each t. 
θ 0= the mean level of the In L/S in samples collected in the pe­
riod 1 9 7 < t < 2 1 0 . Exp ( θ 0 ) = the median value of the L/S ratio 
in this period. 
9,= the daily increase in the mean value of the In L/5 after the 
210th day (MA) of pregnancy ( 2 1 0 < t < 2 8 0 ) . (Exp( 70,)-! ) χ 100% = 
the percentual increase per week of the median L/S ratio be­
tween the 30th and the 40th week of menstrual age. 
The estimates for the model parameters θ 0 , θ , and a b a s e d on the 
model subset data are: 
л 
θ0= -0.05632 + 0.21650 indicating a median L/S ratio of 0.95 un­
til the 30th week (MA) of pregnancy. 
л 
θ,= 0.02268 +_ 0.00275 indicating a weekly percentual increase in 
the median L/S ratio of IBS or a doubling in each 4-week pe­
riod. 
л 
C = 0.61236 indicating a coefficient of variation of 67% in the 
L/S ratio of samples within the same menstrual age. 
Characteristic values for the L/S and In L/S, based on the model, 
are qiven in table VII.IV and the figures 7.2.2. and 7.2.3. 
The model gives a good description of the data as can be seen 
from figures 7.2.2/7.2.3 and from table VII.V. which shows the 
estimated mean values of the L/S ratio in comparison with the ob­
served mean values of the menstrual age in weeks. 
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Table VII.IV. 
Estimate of the percentiles P2.5, P50 a n d P97»5 of the 
L/S ratio for .amniotic fluid samples with characteris­
tics of the model subset in relation to the menstrual 
aqe. 
MA 
in weeks 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
MA 
in days 
210 
217 
224 
231 
238 
245 
252 
259 
266 
273 
280 
Д 
P2-5 
0.29 
0.33 
0.39 
0.45 
0.53 
0.62 
0.73 
0.86 
1.00 
1. 17 
1.38 
P50 
0.95 
1.10 
1.28 
1.50 
1.76 
2,07 
2.42 
2.84 
3.33 
3.90 
4.57 
^97-5 
3.15 
3.65 
4.25 
4.98 
5.84 
6.87 
8.04 
9.43 
11.1 
13.0 
15.2 
L/S ratio 
14 
12 
10 
о" о 8& о lì. o°B 8 β" β 
"»η о „ ^ — 
τ 1 1 Γ 
200 210 220 230 240 250 260 270 2ΘΟ 
menstrual age in days 
Flqure 7.2.2. L/S ratios and estimatpd pprcpntilps P2-5. p50 4 ρ97·5 
in relation to the menstrual age (model subset) 
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Table VII.V. 
Check of the model fit by comparing estimated mean L/S 
ratio with the observed values for the model subset. 
Menstrual age Number Observed 
in weeks Mean SEM 
Estimated mean values within 
the two-phase regression model 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
2 
6 
5 
9 
23 
27 
38 
51 
54 
33 
13 
6 
0 . 7 5 
1.27 
1 . 0 8 
1.86 
1 .40 
2 . 0 5 
2 . 4 5 
2 . 8 2 
3 . 4 1 
3 . 1 9 
3 . 8 7 
5 . 6 2 
0 . 1 5 
0 . 2 2 
0 . 3 9 
0 . 4 1 
0 . 1 7 
0 . 2 7 
0 . 2 5 
0 . 3 1 
0 . 2 9 
0 . 3 2 
0 . 5 6 
0 . 9 0 
1 . 1 4 
1 . 1 4 
1 . 2 2 
1 . 4 3 
1 . 6 8 
1 . 9 7 
2 . 3 0 
70 
16 
71 
34 
09 
G r a p h i c a l p r e s e n t a t i o n i s g i v e n i n f i g u r e 7 . 2 . 1 . 
In (L/S) 
3 0 -, 
2 0 -
1 0 
OO 
10 
— ι 1 τ ι 
2 0 0 210 220 
— ι 1 — ι • 1 1 1 1 1 1 r-
230 240 250 260 270 2ΘΟ 
menstrua l age in days 
F i g u r e 7 . 2 . 3 . L n ( L / S ) a n d t h e e s t i m a t e d p e r c e n t i l e s P 2 . 5 , P50 4 P 9 7 . 5 
I n r e l a t i o n t o t h e m e n s t r u a l age ( m o d e l s u b s e t ) 
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Z-scores or standardized residues are defined as: 
obs. In L/S -estim. model mean In L/5 at the time of observation 
z= 
л 
σ 
So ζ is the standardized distance From the observed In L/S to the 
estimated mean value at the time of observation. 
The distribution of the z-scores For the model subset is compared 
with the standard normal distribution in table VII.VI. In a well-
fittinq model both distributions should be almost identical. 
Table VII.VI. Distribution of the z-scores compared with the 
standard normal distribution N(0,1) 
cumul a 
percen 
10 
20 
30 
40 
50 
60 
70 
80 
90 
t 
t 
N(0 
i ve 
aqe 
1) 
percent ile 
point 
-1.28 
-0.84 
-0.52 
-0.25 
0 
0.25 
0.52 
0.84 
1.28 
Distribution of z-scores 
cumulative percentaqe 
10.1 
23.6 
31.1 
37.5 
48.7 
61.0 
70.0 
79.4 
89. 1 
There is a qood correspondence between the distribution of the 
z-scores and the standard normal distribution. 
Z-scores based on the aforementioned model are the basic statis­
tics For further analysis. (When compannq qrnups For their L/S 
values, an adjustment has to be made for a diFFerence in menstru­
al aqe ) . 
Table VII.VII. relates z-score to the correspondιnq percentile of 
f i qure 7.2.1. 
7.2.2. Statistical procedure For testinq the random srattennq of 
a qroup of points with respect to the percentile lines qi-
ven in fiqure 7.2.3. 
Within a certain group the L/S values are siqmfirantly different 
from the model subset iF z"vn<-1.96 or z\'n>1.96 
with ζ = mean z-score For the qroup 
η = number oF pctients in the qroup 
The p-value accordinq to this test is calculated as: 
ρ = Pr (|u|zVn), were u is standard normal distributed. 
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Table VII.VII. The corresponding percentiles for the Z-scores 
percentile Z-score 
IS 
2.5Й 
b% 
IOS 
20Я 
ЗОЙ 
40% 
50% 
60% 
70% 
B0% 
90% 
ЭЪ% 
97. Ъ% 
99% 
33 
96 
65 
28 
-0.84 
-0.52 
-0.25 
О 
0.25 
0.52 
0.84 
1.28 
65 
96 
33 
7.2.3. The pathway of the analysis. 
For a further analysis of factors possibly influencing the L/S 
ratio and/or the fetal outcome, it seemed appropriate to form an 
analysis-schedule. 
The analysis was carried out according to the lines of the follo­
wing scheme. 
Schematic representation of the influence of groups of variables 
on the outcome of the pregnancy 
Fetal growth retardation 
Prematurity 
The outcome of a pregnancy in regard to the neonatal lung func­
tion depends on variables which can be grouped into: 
R;: events before pregnancy: e.g. diabetes mellitus or habitual 
abort ion 
R2: events during pregnancy: gestational diabetes ,rhesus sensi­
tization, hypertension, albuminuria and oedema. AI30 the use 
of beta adrenergic drugs must be taken into account. 
perinatal complications, such as fetal growth retardation, 
premature delivery, hypoxia during delivery or RDS. 
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These events can influence each other and also the level of the 
L/S ratio in amniotic fluid. 
In this thesis the impact of factors Rj, R2 and the use of beta 
adrenergic drugs on the L/S ratio and the relation between the 
L/S ratio and the occurence of RD5 was studied. 
7.2.4. Overall results 
The mean z-scores (z) and correlation coefficients (r) between 
the z-score and the menstrual age in the subgroups are given in 
table VII. V I H . 
Table VII.VIII. Mean z-scores (z) and correlation-coefficients 
(r) between z-score and amenorrhoe in some sub­
groups with and without events from Rj and R2 a n c' 
the use of beta adrenergic drugs. 
Subq 
Stat 
from 
no 
yes 
no 
yes 
no 
yes 
no 
yes 
roup-
es 
Rl 
forma 
Stat 
from 
no 
no 
yes 
yes 
no 
no 
yes 
yes 
tion 
es 
R2 
* 
Use of 
beta 
adrenergic 
drugs 
no 
no 
no 
no 
yes 
yes 
yes 
yes 
η 
113 
7 
12β 
9 
29 
1 
12 
3 
ζ 
-.0258 
.ЭВ51 
-.0452 
.2333 
.2683 
.0628 
.3592 
.5368 
p-value 
random 
scat te­
ring 
.78 
.11 
.61 
.48 
.15 
-
.21 
.35 
r(z,t) 
.055 
.345 
.055 
.023 
.030 
_ 
.161 
-
* Singleton pregnancies between 197 and 280 days of menstrual age 
without the use of dexamethasone or methy1dopa-chloorthalidone . 
If the membranes were ruptured this had not been longer than 24 
hours. 
This rough analysis indicates: (1) hardly any influence of states 
from R2! (2) a positive influence of states from RIJ (3) a posi­
tive influence of the use of beta adrenergic drugs. 
The influence of the individual factors from Rj and R2 as well as 
the effect of beta adrenergic drugs on the L/S ratio is now ana­
lysed more specifically by means of the generalized linear model 
technigue. An overview of the results of this analysis is given 
in table VII.IX. 
VII.IX. Impact of individual factors on the L/S ratio 
Generalized linear Model* multiple corr. 
coefficlent 
Ζ versus Ri 
R2 
Beta adrenergic drugs (BD) 
Rl+ R2 
Rl+ (BD) 
R2+ (BD) 
Ri + R2 + (BD) 
.10 
.03 
.11 
.10 
.15 
.11 
. 15 
Model sum 
of squares 
2.99 
0.25 
3.61 
3.15 
6.Θ5 
3.99 
7.25 
3.47 
0.07 
8.15 
3.81 
8.32 
degrees of 
freedom 
df 
Ρ 
.08 
.62 
.06 
.37 
.08 
.26 
.40 
.06 
.79 
.04 
.28 
.14 
Diab. mellitus (DM) 
Hab. abortions (HA) 
DM + BD 
HA + BD 
DM + HA + BD 
.11 
.01 
.16 
.11 
.17 
•Singleton-pregnancies between 197 and 280 days of the menstrual age without the 
use of dexamethasone or methyldopa-chloorthalidone. If the membranes were ruptured 
this had not been longer than 24 hours. 
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From the results one may conclude that: 
1) L/S values of amniotic fluid samples in diabetic pregnancies 
are higher. 
2) L/S values during the use of beta adrenergic drugs are higher. 
3) Hypertension, rhesus sensitization and gestational diabetes 
seem to have no influence on the L/S ratio of amniotic fluid. 
For comparisons between two groups it is necessary not only to 
adjust for the menstrual age but also for the presence of diabe­
tes mellitus and for the use of beta adrenergic drugs. The adjus­
ted residual value ζ for these factors is indicated by Zc· 
Zc= Ζ + 0.03707 - 0.49197 χ DM - 0.34850 χ HD + 0.74057 χ DM X BD 
with DM = 0 if diabetes mellitus is absent 
DM = 1 if diabetes mellitus is present 
BD = 0 i f no beta adrenergic drugs are used 
BD = 1 if beta adrenergic drugs are used 
7.3. Diabetes mellitus 
Defini tions : 
All patients already using insulin before becoming pregnant are 
defined as diabetic patients. The patients starting insulin the­
rapy during pregnancy are defined as gestational diabetic pa-
t ients. 
7.3.1. 
Prior to the discovery of insulin the maternal and perinatal mor­
tality in patients with diabetes was high. Careful prenatal care 
and vigorous control of blood giucose values by insulin Injec­
tions or infusions and dietary prescriptions have yielded obste­
trical results which are almost comparable to controls (Gabbe et 
al., 1977; Ло апо іс et al., 1981). 
The direct influence of diabetes mellitus on the incidence of HDS 
has been studied thoroughly during the past years (table VI I . X. ). 
This incidence can be correlated with the values of the I/S ratio 
which depend on menstrual age. 
The complications of diabetes mellitus and obstetrical outcome is 
also closely related to the duration of diabetes and the presence 
or absence of vascular lesions. These variables were summarized 
by Priscilla White in her classification of diabetes during preg­
nancy (1949), a classification which was used in table П.Х. 
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Table VII.X. Influence of diabetes mellitus on lunq maturation 
Delayed 1 
G 
H 
В 
В 
G 
W 
S 
A 
С 
R 
С 
M 
H 
К 
Τ 
H 
Τ 
( Anim 
С 
h 
E 
к 
S 
В 
Accélérât 
В 
G 
G 
M 
G 
Unchanged 
U 
D 
G 
Τ 
С 
Τ 
τ 
ung 
elli 
ubbe 
огег 
rude 
luck 
hitf 
inqh 
ubry 
ruz 
ober 
unni 
uell 
al lm 
u lov 
sai 
al lm 
sai 
al e 
heek 
ave 
pste 
eys 
osen 
ose 
ed 1 
огег 
luck 
luck 
uell 
luck 
lun 
sher 
ahle 
abbe 
chob 
ure t 
ahsh 
sai 
maturai 
s 4 Hsi 
11 A Dr 
et al . 
nell 4 
4 Kulo 
ield et 
et al. 
et al. 
et al. 
t et al 
nqham e 
er-Heub 
an 4 Te 
ich 4 G 
4 Marsh 
an et a 
et al. 
xperime 
et al. 
reduced 
in et a 
ko et a 
et al . 
ung mat 
et al. 
4 Kulo 
et al. 
er-Heub 
(1978) 
q matur 
et al. 
nburg e 
et al. 
rout sky 
et al'. 
et al. 
et al . 
ion : 
a (1959) in all classes of diabetes 
orbauqh (1965) in all classes of diabetes 
(1971) in class А, В, С 
Beard (1972) in all classes of diabetes 
vich (1973) in class А, В, С 
el. (1973) in all classes of diabetes 
(1974) in class А, В, С 
(1976) in class А, В, С 
(1976) in insulin-dependent diabetes 
. (1976) in all classes of diabetes 
t al. (1978) In class A only 
ach et al. (1978) in class А, В, С 
ramo (1979) in class A only 
luck (1979) in class A only 
all (1979) in diabetes (not classified) 
1. (1982b) in class A only 
(1984) in class B, C, D-F-R diabetes 
nts) : 
(1973) streptozotocin treated primates 
lung weights 
1. (1976b) streptozotocin injected Rh. mon-
1. (1980) alloxan treated rabbits 
(1980) alloxan treated rabbits 
urat ion : 
(1971)! Class D, F,R 
vich (1973): Class D, F, R 
(1974b): Class D, F, R 
ach et al. (197B): Class D only 
: class D, F, R 
at ion: 
(1971): not classified diabetes 
t el. (1977): Class А, В, С 
(1977): Class В, C, 0, F, R 
et al. (1978): Class В, С, D., F, R 
(1979): insulin-dependent diabetes 
(1982): insulin-dependent diabetes 
(1984): Class A diabetes 
In the literature there is almost agreement concerning an accele­
ration of lung maturation in classes D, F and R. This aqreement 
is not always found in the other classes. 
Some investiqators noticed a high percentage of false positive 
results in predicting RDS from L/5 ratios in cases of diabetes 
mellitus (Farrel (1976): 7-18Ж; Dahlenburq et al. (1977):273S; 
Mueller-Heubach et al. (1978): 18%; Kitzmiller et al,(1978): 
12, b°í) . However, other investigators reported a lower percentage 
of false positive results (Gabbe et al. (1977): 3$; Lowenaohn 4 
Gabbe (1979): 5^; Tabsh et al. (1982): 3,9й). 
Because of this controversy we paid more attention to the total 
lunq profile (see chapter 8 ) . We considered it of interest to see 
whether the amount of false positive predictions could be reduced 
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by the use of the total lung profile in patients with diabetes. 
According to the studies of Teramo 4 Hallman (19B0) and 
Cunningham et el. (1982) this test had a higher predictive value 
than the L/S test. 
James et al. (19Θ4) suggested that the measurement of the concen­
tration of lecithin and PC appeared also to predict fetal lung 
maturity more accurately than an L/S ratio determination combined 
with a simple recording of the presence or absence of PG. 
The large range in percentage of false positive results, аз men­
tioned before, could also be due to: (1) different ways of defi­
ning RDS, (2) inclusion of class A diabetes in the studies, and 
(3) methodological differences in the preparation of specimens 
for the determination of the L/S ratio (Cherayil et al., 1977). 
A possible reason for a delay in lung maturation in neonates born 
to diabetic mothers is their non-normoglycemic status. Maternal 
hyperglycemia also causes fetal hyperglycemia which leads to a 
greater production of insulin in the fetus. Through this mecha­
nism a number of changes in the composition have been observed 
such as: 
1) a decreased fetal myoinositol concentration in lung tissue 
(Merrit et al., 1981), 
2) an increased plasma myoinositol concentration leading to the 
formation of more phosphatidylinosito 1 instead of phosphati-
dylglycerol (Hallman 4 Epstein, 1980), 
3) a decreased level of CDP-diglyceride; inositolphosphatidyl-
transferase which lowers the concentration of phosphatidyl ino­
sitol in lung tissue and therefore diminishes the production 
of phosphatidylglycerol (Hallman et el., 1982b). 
7.3.2. Results 
In the population studied 21 patients suffered from diabetes 
mellitus; 7 of these were classified as belonging to group B, 13 
belonged to group С and one of them to group D. Since 1 patient 
was treated with a beta adrenergic drug at the time of sampling 
only the data from 20 patients are shown in figure 7.3.1. 
With the aid of insulin administration subcutaneousl у and diet 
the blood glucose levels of all patients were kept between 4.0 
and 7.0 mmol/1. 
As can be seen from figure 7.3.1. most values (11/20) are located 
л 
above the P50 of the model subset. These results give a z-score 
of .4549 and corresponding p-value of .06 (see table VII.IX). 
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τ 1 1 1 1 1 1 1 1 1 Γ 
200 210 220 230 240 250 260 270 2Θ0 
menstrual age in days 
F i g u r e 7 . 3 . 1 . L n ( L / S ) i n d i a b e t i c p a t i e n t s i n r e l a t i o n t o t h e 
m e n s t r u a l age ( s o l i d l i n e s are t h e Ρ2·5> P50 * Γ 9 7 . 5 f r o m t h e 
model s u b s e t ) . 
1 0 1 
2 0 0 210 220 230 240 2 5 0 260 270 280 
menstrual age in days 
F i a u r e 7 . 3 . 2 . L n ( l . / S ) i n p a t i e n t s w i t h g e s t a t i o n a l d i a b e t e s i n 
r e l a t i o n t o the m e n s t r u a l age ( s o l i d l i n e s are the Ρ2·5» ^50 * 
P97.5 From t h e model s u b s e t ) . 
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The gestational diabetes patients (n=19) are scattered at random 
around the P50 (see Figure 7.3.2.). In this study gestational 
diabetes had no detectable inFluence on the L/S ratio. 
In the whole group there were no False positive L/S ratios. 
7.4. Vascular disorders 
DeFinition: This study group consists oF the patients who had a 
diastolic blood pressure oF 90 mm Hg or more on at least two oc­
casions during pregnancy. 
7.4.1. 
No consensus was found in the literature on the inFluence of vas­
cular disorders on Fetal lung maturation. Various authors have 
suggested accelerated pulmonary maturity in such pregnancies but 
this has not been conFirmed (see table VII.XI). 
Table VII.XI. Influence of hypertension on fetal lung maturity 
accelerated 
lung maturation 
Gluck 4 Kulovich (1973) 
Aubry et al.(1976) 
Muller-Tyl 4 Salzer 
1978a) 
Bustos et al.(1979) 
Kulovich 4 Gluck (1979) 
Bent et al.(1982) 
uninfluenced 
lung maturation 
Whitfield (1973) 
Freeman et al. (1974) 
Tuimala (1978) 
Skjaeraasen (1979) 
Diedrich et al. (1981) 
decreased 
lung maturation 
Doran et al. (1976) 
The investigation of Skjaeraasen (1979) is especially interes­
ting; even severe preeclampsia (bloodpressure above 160/100 mm Hq 
and/or albuminuria more than 0.2%) did not accelerate pulmonary 
maturation. 
If hypertension was treated successfully the RDS incidence was 
similar to that in the group of non-hypertensive patients 
(Tchobroutsky et al., 1982). 
7.4.2. Results 
Hypertension was diagnosed 12Θ times. 
No difference was seen between this group and the model subset 
(figure 7.4.1.). Our results were similar to those of Skjaeraasen 
(1979) if only the patients with a diastolic blood-pressure abo­
ve 100 mm Hg were taken into account (n = 3;ZC = - .8816). 
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200 210 220 230 240 250 260 270 2Θ0 
menstrual age in days 
Figure 7.4.1. Ln(L/S) in patients with hypertension in relation 
to the menstrual age (solid lines are the P2-5» •?() * Ρ97·5 from 
the model subset). 
7.5. Fetal growth retardation 
Definition: The weight for gestational age of the infant at birth 
13 below the IDth percentile (Kloosterman, 1 9 7 3 ) . 
7.5.1. 
Accelerated maturation has been described by Lindback (1976) in 
p r e q n a n n e s with fetal growth retardation. Other authors have not 
confirmed this change (Dewhurst et al., 1973; Whitfield, 1973; 
Runston 4 Davey, 1978). Dyson et al.(1975) found even lower L/S 
ratios in pregnancies with intrauterine growth retardation at 37-
39 weeks of gestation. The same conclusion can be drawn from the 
study of Skjaeraasen (1979). 
On the other hand less RDS is seen in chronically distressed 
growth retarded fetuses (Gluck 4 Kulovich, 1973; Kulovich 4 
Gluck, 1979;Sher et al., 1981). 
In the lung profile PC seems to appear earlier in growth retarded 
fetuses and Gross et al. (1981) stated that PG may be helpful in 
classifying small infants as either growth retarded or preterm. 
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270 2ΘΟ 290 
menstrual age in days 
Figure 7.5.1. Ln(L/S) in 
growth retarded Fetuses « P ¿ • 5) in relation to the menstrual age 
(solid lines are the Г2 
pregnancies resulted in the birth oF 
ίη relat ion to 
1*50 4 P97-5 from the model subset). 
ln(L/S) 
30 -, 
20 
10 
00 
10 
200 210 220 230 240 250 
Figure 7.5.2. Ln(L/5) in pregnancies 
growth retarded Fetuses (Ι^2·5-Ρ5) l n 
age (solid lines are the Ρ2·5, ^50 * 
set) . 
260 270 280 
menstrual age in days 
resulted in the birth oF 
relation to the menstrual 
P97.5 From the model sub-
61 
ι г 
200 210 220 230 240 250 260 270 280 
menstrual age in days 
Figure 7.5.3. Ln(L/S) In pregnancies resulted in the birth of 
growth retarded fetuses (P5-P10) i n relation to the menstrual age 
(solid lines are the P2.5. P50 * ^97-5 from the model subset). 
7.5.2. Results 
The number of growth retarded fetuses in the investigated popula­
tion was Θ7. No accelerated L/S ratios were seen. This group was 
subdivided into 3 sub-groups: 
- between the 10th and 5th percentile (n = 27; figure 7.5.3) 
- between the 5th and 2.5 percentile (n= 27; figure 7.5.2) 
- beneath the 2.5 percentile (n= 33; figure 7.5.1) 
Even in this last group of patients the L/S ratios did not differ 
statistically from these of the model subset. 
Subdivision in patients with end without hypertension did not 
make any difference ( Z
c
 respectively -.3330 and - . 3 2 8 4 ) . 
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7.6. Beta adrenergic drugs 
7.6.1. 
An review of the literature is given in chapter 5.2.. A positive 
effect of beta adrenergic drugs on lung maturation has been re­
ported in the literature. Besides a possible direct effect these 
drugs may of course also prolong gestation. 
7.6.2. Results 
In A5 patients treated for premature contractions, L/S ratio de­
terminations were done during intravenous beta adrenergic drug 
administration. All patients were treated because of premature 
contractions and to prevent premature delivery. 
The results expressed in figure 7.6.1. demonstrate a higher value 
of the L/S ratio in this group compared to the values gathered in 
the model subset (z-score = . Я 1 4 ; РбО-70! Ρ = .06). 
For a correct interpretation of these results it must be taken 
into account that these patients are near to the time of delive­
ry. We took the L/S ratios at parturition and compared these data 
with the values at the same menstrual age in pregnancies which 
still continued. 
In (L/S) 
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2 0 
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oo 
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• diabetic patient 
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F i g u r e 7 . 6 . 1 . L n ( L / S ) i n p a t i e n t s t r e a t e d w i t h b e t a a d r e n e r g i c 
d r u g s i n r e l a t i o n t o t h e m e n s t r u a l age ( s o l i d l i n e s . i r e t h e Ρ 2 · 5 » 
^ 5 0 * Ρ 9 7 · 5 f r ° m t h e m o d e l s u b s e t ) . 
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We observed that the values were higher than expected if the mo­
ment of delivery was nearer (all groups of samples had a positive 
z-score until term). Table VII.XII. illustrates this point. 
Table VII.XII. Estimated median L/S ratios in relation to the 
time of delivery 
Median L/5 ratio 
Number of days 
before delivery 
224 
Menstrual age in days at the time of 
delivery 
238 252 266 2Θ0 
0 
3 
7 
14 
Comparable L/S 
ratio at the same 
menstrual age 
1.75 
1.67 
1.57 
1.41 
і.гв^ 
2.25 
2.15 
2.02 
^1.82 
' / 
1.76-/ 
2.89 
2.76 
2.60 
^2.33 
' / 
2 . 4 2 ^ 
3.71 
3.55 
3.34 
^3.00 
' / 
З . З З ^ 
4.77 
4.56 
4.29 
^3.86 
/ 
4.57 
The suggestion that accelerated lung maturation has occured or 
still occurs in pregnancies complicated by premature contractions 
is probably in agreement with the findings of Brame 4 MacKenna 
(1983). They observed in some cases of PROM PG in the amniotic 
fluid. The patients did not have "any of the maternal diseases 
usually associated with advanced lung maturation". 
7.7. Rhesus sensitization 
Definition: patients with anti D antibodies in their sera and 
rhesus positive infantq. 
7.7.1. 
Hardly any work has been done on the L/5 ratio of amniotic fluid 
from rhesus sensitized women. The few available data suggest a 
delayed maturation (Whitfield et al., 1972; Aubry et al., 1976; 
Müller-Tyl Λ Salzer, 197fla; Tsai et al., 1984), although Bayer et 
al. (1973) saw an increase in lung maturation in such patients. 
However recently Buhi et al.(1983) presented data from which no 
effect on fetal lunq maturation was detected (as judged by the 
L/5 ratio). 
Caritis et al. (1977) tried to accelerate pulmonary maturity in 
rhesus sensitized pregnancies by administration of betamethasone. 
The changes in L/S ratio following steroid therapy were small but 
there were reduced guantities of bilirubinoiri pigments in the 
amniotic fluid. It remains to be proven whet IT er the hemolytic 
disease in the fetus can regress by steroid therapy or whether 
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the improvement is due to other factors. 
7.7.2. Results 
In 11 rhesus sensitized pregnancies L/S ratios were determined: 
4-tinies only one sample was taken and once only two sairples were 
taken. In the other 6 pregnancies the L/S ratios were determined 
three to eight times. All values are given in figure 7.7.1. 
From these measurements no overall positive effect on the L/S ra­
tio was found. In 6 out of the 11 pregnancies the L/S ratios were 
measured above the P ^ Q . The data suggest an accelerated lung ma­
turation in patients in the Liley group III. 
In (L/S) 
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Figure 7.7.1. Ln(L/S) in rhesus sensitized preqnanries in rela­
tion to the menstrual aqe (solid lines are the Ρ2·5» P^O 4 Ρ97·5 
from the model subset). 
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7.θ. Multiple pregnancies 
7.8.1. 
Although the second-born twin is reported to have a greater risk 
of RD5 than the first-born (Rokos et al., 1968) the L/S ratios 
are closely related (Sims et al., 1976). Of all babies developing 
RDS 25Й were twins (Farr, 1975); the risk that the second-born 
twin has RDS is twice as high as that of the first-born twin 
(Rokos et al., 1968; Farr, 1975). 
In the literature conflicting data have been reported on this 
subject: Parkinson et el. (1980) found no significant difference 
in L/S ratios between twin and singleton pregnancies of the same 
gestational age, while Leveno et al. (1983) saw accelerated lung 
maturation in twin gestations (mean L/S ratio above 2.0 at 32 
weeks of pregnancy in twins). With the onset of labor there was a 
significant rise in amniotic fluid L/S ratios in the first twin 
compared with those of the second twin of the same pregnancy 
(Norman et al., 1983). Dobbie et al. (1983) found in twin preg­
nancies a weak correlation between the L/S ratios but a much im­
proved one for PG/S and PI/S. The concordance between sacs for 
all three ratios was better in monozygotic than in dizygotic 
twins. 
On the other hand the increased incidence of respiratory distress 
syndrome in twins can be related to a number of perinatal events 
(Leveno et al., 198 3 ) . 
7.8.2. Results 
L/S ratios were measured in 26 twin pregnancies. Two were exclu­
ded from statistical analysis; one because of prolonged rupture 
of the membranes and another because of treatment with cortico­
steroids before amniotic fluid sampling. 
The data from the twin pregnancies are given in figure 7.8.1. 
Compared with singleton pregnancies at the same menstrual age 19 
out of 24 L/S ratios were above the P50 (z-score .7318; p-value 
.0004). 
The only false positive L/5 ratio was seen in this group: a se­
cond born twin at 224 days (menstrual age) with a L/S ratio of 
2.2 in vaginally collected amniotic fluid suffered from RDS. The 
girl survi ved. 
In 8 cases the origin of the amniotic fluid sample was not exact­
ly known (it was uncertain from which amniotic sac the sample was 
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Figure 7.8.1. Ln(L/S) in twin pregnancies in relation to the men­
strual age (solid lines are the Ρ2·5» PjO 4 Ρ97·5 from the model 
subset). 
t a k e n ) . There is no reason to believe that there is a great dif­
ference between the L/S ratios of the two fetuses before parturi­
tion especially if their growth is almost the same (Leveno et 
al., 1984). In our study in all hut two cases the birth weights 
of the two children were almost the same. In these two cases the 
difference was more than 20%. In four of the others the differen­
ce was less than 7%. 
7.9. Premature rupture of the membranes 
Definition: premature rupture of the membranes (PROM) is the rup­
ture of the membranes before the onset of labor irrespectively 
of menstrual age. 
7.9.1. 
The management of premature rupture of the membranes is still 
controversial: only after the 36-37th week of gestation is there 
more agreement. Delivery is always induced if the membranes have 
been ruptured for more than 24 hours. 
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Differences in the management exist especially between the 34th 
and 37th week of gestation: before the 34th week of pregnancy 
most obstetricians will not consider active treatment. 
The incidence of PROM is about 5-105; in cases of prematurity the 
incidence is higher (table VII.XIII. and VII.XIV.). 
Table VII.XIII. Incidence of PROM in all pregnancies 
Incidence of PROM in all pregnancies 
Atkins ΓΓ949Τ 7,9S 
Bada et al. (1977) 
Bréese (1961) 
Calkins (1952) 
Christensen et al.(1976) 
Embrey (1953) 
Fayez et al. (1978) 
Flowers et al. (1958) 
Lanier et al. (1965) 
Lebherz et al. (1961) 
Miller et al. (1978) 
5 
6,4% 
15,2« 
0,78-2,ÍS 
13, 9% 
1,6% 
15,8S 
6,23 
7,Ой 
10% 
Table VII.XIV. Incidence of PROM in premature deliveries 
Incidence of PROM in premature deliveries 
Alden et al.(1972) 29Й 
Bourne (1962) 34Й 
Bréese (1961) 23,5S 
Gillebrand (1967) 32,6« 
Bada et al. (1977) found an incidence of 5Й PROM with 28% preterm 
deliveries. In this study from all neonatal deaths, 53% (22 out 
of 43) was due to RDS. The morbidity due to RD5 was 13%; all neo­
nates were born before the 37th week of pregnancy. Up to the 33rd 
week of pregnancy all but one of the neonates who developed RDS 
died from the disease regardless of the duration of the rupture 
of the membranes. From their data they concluded that a conserva­
tive approach was justified until the 33rd week of pregnancy; af­
ter that period a more aggressive approach was advisable because 
of the higher incidence of neonatal sepsis and asphyxia. 
Other investigators were able to show a decreased incidence of 
ROS after prolonged rupture of the membranes. A conservative ma­
nagement was justified also after the 33rd week of gestation if 
there were no signs of intrauterine infection (Chiswick 4 
Burnard, 1973; Richardson et al., 1973; Yoon S Harper, 1973; 
Bauer et al., 1974; Richardson et al., 1974; Stinson et al., 
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1977; Thibeault 4 Emmanoui 11 ides, 1977; агпег 4 Galask, 1981). 
The different investigators gave different rules for the manage­
ment of PROM: table VII.XV. summarizes the time-schedule within 
which a conservative management was proposed. 
Table VII.XV. Different recommendations about the conservative 
management-period 
Author(s) (Year) 
Gil lebrand 
Johnson 4 Barnes 
Chiswick 4 Burnard 
Bauer et al. 
Jones et al. 
Berkowitz et al. 
Bada et al. 
Mead 4 Clapp 
Fayez et al . 
Kappy et al. 
Eggers et al. 
Varner 4 Galask 
Brame 4 MacKenna 
1967) 
1970) 
1973) 
1974) 
1975) 
1976) 
1977) 
1977) 
1978) 
1979) 
1979) 
19Э1) 
1983) 
Conservât 
just 
34th 
37th 
35th 
36th 
37th 
36th 
33rd 
34th-
541 h 
37th 
36th 
36th 
36th 
Lfied 
week 
week 
week 
week 
week 
week 
week 
-36th 
week 
week 
week 
week 
week 
tve 
un 
of 
of 
of 
of 
of 
of 
of 
management 
.il the 
pregnancy 
pregnancy 
pregnancy 
pregnancy 
pregnancy 
pregnancy 
pregnancy 
week of pregnancy 
of 
of 
of 
of 
of 
pregnancy 
pregnancy 
pregnancy 
pregnancy 
pregnancy 
Besides respiratory distress and intrauterine infection the most 
frequent cause of neonatal morbidity and mortality in prematurity 
is the presence of a persistent fetal circulation (Alden et al., 
1972; Fayez et al., 1978; Varner 4 Galask, 1981; Daniels, 1982). 
Thibeault 4 Emmanoui 11 ides (1977) and Varner 4 Galask (1981) 
showed a marked reduction of patent ductus arteriosus after res-
pectively 72 hours and 4Я hours of PROM between respectively 
the 25th and 34th week and the 2 4th and ЗбіЬ week of gestation. 
The incidence of RDS in preterm deliveries with prolonged rupture 
of the membranes is given in table VII.XVI. tThe figures in raies 
without ruptured menhranes are given in chapter 3). 
In an attempt to decrease the incidence of ROS, even in cdses of 
PROM, some obstetricians give corticosteroids. га оиг.эЬІе results 
without an increase in the incidence of neonatal infection1« were 
described by Mead 4 Clapp (1977). Чоие эг, this has not been con­
firmed by Eggers et al., 1979, Barrett 4 Iloehm, Γ1'!?, uni 
Herbert, 1983. 
The mechanism behind the arceleration of fetal lum) τ a t u n 1 ] ο η 
is not fully understood hut in cases if ''HOM, elevated eortisnl 
concentrations have been reported to IT1 r^sonnsι h In 'Cohen et 
al., 1976). The acceleration can ,jlso be lerii/ed f г un ' ir Litt 
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ІаЫе VII.XVI. Incidence of RDS with prolonged rupture 
of the membranes 
Menstrual 
age 
28-32 weeks 
33-37 weeks 
less than 32w. 
less than 35w. 
27-32 weeks 
25-26 weeks 
27-28 weeks 
29-30 weeks 
31-32 weeks 
33-34 weeks 
less than 34w. 
26-29 weeks 
30-33 weeks 
54-37 weeks 
over 57 weeks 
28-34 weeks 
Duration of 
PROM 
24-48 hours 
40-72 hours 
over 72 hours 
24-48 hours 
49-72 hours 
over 72 hours 
over 24 hours 
over 24 hours 
over 24 hours 
over 24 hours 
over 24 hours 
over 24 hours 
over 24 hours 
27-32 weeks , over 24 hours 
less than 
36 weeks over 24 hours 
'ess than , 24-48 hours 
56 weeks j 49-72 hours 
іо ег 72 hours 
27-30 weeks 
31-34 weeks 
35-5B weeks 
25-34 weeks 
28-56 weeks 
li'4s then34 w. 
over 24 hours 
25-48 h. 
49-72 h. 
over 72 h. 
24-48 hours 
48-7 2 hours 
over 72 h. 
over 24 h. 
Morbidity 
due to RDS 
38% 
20% 
20% 
7% 
11% 
10% 
32% 
27% 
38% 
100% (83%)*1 
25% (40%) 
13% (33%) 
44% 
10% (17%) 
27% 
56% 
12% 
0,6% 
0,3% 
8% 
81% (22%)* 
Authors (Year) 
Bada et al. (1977) 
Berkowitz et al.(1976) 
Chiswick 4 Burnard(1973) 
Christensen et al.(1976) 
Eqqers et al.(1979) 
Fayez et al. (1978) 
Jones et al.(1975) 
Kappy et al.(1979) 
Mead 4 Clapp(1977) 
31% ¡Richardson et al.(1973) 
40% 
33,3% 
22% 
62% 
30% 
1% 
33% 
10% 
OS 
2 5,8% 
22,2% 
22,2% 
12,5% 
Richardson et al.(1974) 
Stinson et al.(1977) 
Thibeault 4 Emmanoui 11 ides 
(1977) 
Varner A Oalask (1981) 
Yoon 4 Harper (1973) 
("percentdUüs of RD'Ì after corticostprnid treatment) 
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presented by Whittle et al.(1983) and Brame 4 MacKenne (1983), 
who showed an earlier appearance of PG in the lung profile after 
PROM. 
7.9.2. Results 
The L/S ratio was determined in only ten singleton pregnancies 
with ruptured membranes of more than 24 hours. A significant 
difference with the model subset was not detected (Z
c
 = .2902; p= 
.26). 
τ г 
2 0 0 210 220 230 240 2 5 0 260 270 280 
menstrual age m days 
Figure 7.9.1. (Ln(L/S) in pregnancies after ruptured membranes 
for more than 24 hours in relation to the menstrual age (solid 
lines are the P2.5, ^50 4 P97.5 from the model subset). 
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7.10 Uncomplicated pregnancies 
Definition: This group consists of mothers with a normal preg­
nancy without pathology at the time of amniocentesis. 
7.10.1. 
Data concerning the course of the L/S ratio in uncomplicated 
pregnancies are scarce. Sampling of amniotic fluid by amniocen­
tesis in uncomplicated pregnancies would introduce en unnecessary 
risk for the mother and the fetus. However, under ultrasound con­
trol complications of amniocentesis are rare (Crandon A Peel, 
1979). 
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Figure 7.10.1 Ln(L/S) in uncomplicated pregnancies in relation to 
the menstrual age (solid lines are the Ρ2·5, Pjo à P97.5 from the 
model subset). 
7.10.2. 
The date of 113 pregnancies which were without complications at 
the time of amnincentes is are given in figure 7.10.1. There is a 
wide inter-individual range; however after the 34th week (MA) of 
pregnancy more than 50 percent of the neonates have mature L/S 
ratios. 
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In figure 7.10.2 the data from this group are compared with data 
from the literature; the course of the L/G ratio is the same in 
all studies, however the values of the L/S ratio at the same week 
of pregnancy differ. This Is probably due to the different tech­
niques used in the determinations of the L/5 ratio. 
LIS ratio 
14 
12 
10 
О -
- - Diednch et al 197Θ 
--- Dyson et al 1975 
— Gluck et al 1974(b) 
H e r b e r t et al 197Θ 
Muller-Tyl et al 1977 
2 0 0 210 2 2 0 2 3 0 240 2 5 0 260 270 2 8 0 
m e n s t r u a l age m days 
s o l i d l i n e s ) с о і л p a r e d w i t h d a t a f r o m t h e l i t e r d t u r e . 
Case report 
Very rarely lunq maturity is only rearhed aftpr the 40th week 
(MA) of pregnancy as is shown in figure 7. 10. 5. f h n гчте con­
cerns a fourth pregnancy. The first pregnancy .v.n uneventful ,)nd 
a healthy son was horn. The second and third ρ r^gn.inn ι es wen» al­
so uneventful, however these two children die) respectively •wo 
and five days after birth. The delivery of the 4i>rond H u l l took 
place at home; a girl w,is born who w^s referred to the h o s n i M l 
because of respiratory ргиЬІепь. This Hiild died t w π days later. 
The third delivery took place in the hospital; ·ί boy Λ.ΙΊ hirn 
with asphyxia because of a tight twisted r-orl нгліпі b ι ч neck. 
Oxygen was admin i s tiered hut there w.is no i ιηρ rovcne 11 (pH: ft.92). 
The radiographic pictures of the lungs showed a fine miliary 
mottling. Artificial ventilati m was necessary afte,- w h ι с ι the 
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pulmonary situation seemed to improve. However cerebral damage 
had occurred. The child died the next day with symptoms of RD5. 
Post mortem examination revealed red-purple lunqa which had not 
unfolded sufficiently. Post mortem the clinically observed cere­
bral damage could not be confirmed by microscopic examination. 
The fourth pregnancy was treated with insulin because of a 
slightly abnormal oral glucose tolerance test and a bad obstetri­
cal history. Amniotic fluid analyses showed an L/S ratio above 
2.0 (i.e. 3.2 at a menstrual age of 284 d a y s ) . Then labor was in­
duced under fetal cardiotocoqraphic monitoring. A healthy daugh­
ter was born who had no sign of RDS. An identical case of delayed 
lung maturity was presented by Panter-Brlck (1976) and Farrell et 
al. (1979). However, in their case reports no amniotic fluid mea­
surements were performed. 
In (L/S) 
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Ι l i - m Ι.'] ·!ΐι!ι<-,.'1 ) . 
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8. THE TOTAL LUNG PROFILE 
In 1974 Rooney et al. and Hallman 4 Gluck showed that phosphati-
dylglycerol (PG) was also present in the surfactant of the lung. 
Later the importance of this substance in the surfactant was con-
firmed . 
The synthesis of phosphatidylinositol (PI) and phosphatidylglyce-
rol (PG) is shown in figure 2.1. Phosphatidic acid, a precursor 
of both PI and PG reacts with cytidinetriphosphate to form cyti-
dinediphosphate-diacylglycerol (CDP-diacyIglycerol), which is 
then used in the biosynthesis of phosphatidylinositol and phos-
phat idylglycerol-phosphate , the immediate precursor of phosphati-
dylglycerol (Quirk 4 Bleasdale, 1983). 
The synthesis of phosphatidylglycerol takes place in the endo-
plasmatic reticulum and mitochondria of alveolar type II cells 
(Hallman 4 Gluck, 1974/1975) in the following way: 
1. CDP-diglyceride + sn-glycerol-3-P — > PG-P + CMP 
2. PG-P »PG + Pi 
The same investigators compared the surfactant-composition of the 
healthy neonates with that of neonates suffering from RDS. The 
results are shown in table VIII.I. 
Table VIII.I. Composition of surfactant from healthy neonates 
compared with neonates suffering from RDS (Hallman 
4 Gluck, 1976) 
% phospho 
Healthy neona 
Lecithin 77.9 
PG B.9 
PI 4.2 
PE 5.1 
Bis-(monoacylglycerol )P 1.1 
PS 1.4 
Sphingomyelin 1.0 
1 ipi 
te 
d--P 
Neonate with RDS 
76.2 
0.0 
11.9 
6.0 
0.0 
2.1 
3.0 
In normal pregnancies Hallman et al. (1976) investigated the 
change in the amniotic fluid phospholipid composition with regard 
to gestational age. Up to the 35th week of pregnancy they obser-
ved an increase in the amount of phosphatidylinositol. Afterwards 
phosphatidylglycerol appeared and concomitantly PI decreased. We 
have confirmed these observations (Feijen et al., 1982). The in-
verse relationship between PG and PI is probably caused by a de-
crease during gestation of the fetal serum concentration of myo-
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inositol. The myoinositol content of the maternal serum remained 
however unchanged. The gradual decline in concentration of myo­
inositol in fetal serum causes a decrease in its availability for 
the fetal lungs and may be responsible for the change in the PG/ 
PI ratio (Quirk & Bleasdale, 19Θ3). 
The total lung profile was introduced by Kulovich et al.(1979). 
Its principal components are the L/S ratio, the proportion of 
acetone-precipitable lecithin, PI and PG. 
In normal pregnancies, without complications, the L/S determina­
tion seems to be sufficient for the evaluation of fetal lung ma­
turity. In complicated pregnancies however the total lung profile 
and especially the PG-content is necessary to minimize the risk 
of RDS for the newborn. 
PG is a relatively specific phospholipid of pulmonary origin 
(Hill et al., 19Θ3). It is not essential for surface activity but 
probably improves the properties of the surfactant by stabilizing 
the alveoli (Hallman A Gluck, 1976). According to Hallman et al. 
(1977) RDS will not occur if PG is present. This statement was 
confirmed by other investigators (Cunningham et al., 1977; Bustos 
et al., 1979; Yambao et al., 1981; Stedman et al., 1981). On the 
other hand RDS was seen occasionally even if PG was present 
(Plauché et al., 1982; Whittle et al., 1982; Schmidt-Sommerfeld 
et al., 1982; Barnes et al., 1984). 
PG appears earlier in amniotic fluid in stressed pregnancies 
(Kulovich 4 Gluck, 1979; Obladen et al., 1979b; Gross et al., 
1981;5tedman et al., 1981); PG appeared at least 48-72 hours la-
ter than under normal conditions in pregnancies between 28 and 34 
weeks (MA) complicated by PROM (Stedman et al., 19B1). Bustos et 
al. (1979), Kulovich et al. (1979) and Strassner et al. (1980) 
showed that the determination of PG is not influenced by blood 
contamination. Hill 4 Ellefsen (1983) have shown that meconium 
will interfere with the detection and quantification of PG. Fur-
thermore Dombroski et al. (1981) demonstrated that if PG is pre-
sent in vaginally pooled amniotic fluid it is also present in the 
amniotι с sac. 
8.1. Determination of the lung profile by two-dimensional thin-
layer chromatography. 
Five milliliters of amniotic fluid previously centrifuged for 5 
minutes at l90Ug is placed in a 50 ml tube. Fifteen ml of chloro­
form- m ethanol (2:1, v/v) is added and the content is mixed vigo-
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rously on a rotating mixer for 5 minutes and afterwards centrifu-
ged for 10 minutes at 1300g. The chloroform layer is transferred 
into a 15 ml tube and evaporated under N2 at 37*C. The extract is 
concentrated in the tip of the tube with a few drops of chloro-
form which is then removed by évaporât ion. The test tube is placed 
in ice for 5 minutes. Two drops of aceton are added and the tube 
is slightly agitated. Then 0.75 ml of cold aceton is added. The 
tube is kept in ice for 5 minutes, followed by cent rifugation at 
1300g for 5 minutes. The supernatant is decanted into another tu-
be (= soluble fraction). Both tubes are completely dried with a 
stream of nitrogen. Next 50 /il of chloroform is added to both tu-
bes. Using freshly activated thin-layer plates (see appendix 3) 
the whole solution containing the precipitable fraction is ap-
plied onto the right side of the plate and the aceton-soluble 
fraction is applied onto the left side. Two PG standards are also 
used; one is applied near to the soluble fraction, the other near 
to the right top corner of the plate. Two solvents are used: 
chloroform-methano1-acet ic acid-water (130:50:16:8 v/v/v/v) and 
tetrahydrofuran-methylal-methanol-2M ammonia-water (80:57:15,6: 
4,2:4,2 v / v / v / v ) . The plate is allowed to develop to at least 10 
cm from the origin in the first solvent. Then the plate is remo-
ved from the tank, evaporated and placed into the oven at 70°C 
for 7-8 minutes. Subseguently the plate is cooled to room tempe-
rature and afterwards placed in the second solvent, where the 
spots run perpendicular to the first direction. After the front 
is 10 cm from the origin, the plate is removed and the solvent is 
allowed to evaporate. Then it is placed into the oven at 100'C 
for 10 minutes and afterwards transferred for charring to a pre-
heated plate with a surface temperature of 280°C. When the plate 
is completely charred, it is removed and the spots are measured 
by reflectance densitometry at 500 nm. 
The calculation of the percentages of the different phospholipids 
is as follows: the total area measured by reflectance densitome-
try is 100%. This total area consists of the areas of the acetone 
precipitable lecithin, phosphatidy1inosito 1, phosphatidylglyce-
rol, phoshatidylserine and phosphatidylethanolamine. Each of 
these is divided by the total to obtain the relative amounts ex-
pressed as percentage of the total. 
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8.2. Material and methods 
During a period of approximately 2 years, 174 samples of amniotic 
fluid were obtained from 150 patients. The samples were collected 
either by amniocentesis (60Й) or by amniotomy. In 159 samples 
both the one-dimensional L/S ratio and the total lung profile we­
re determined. For the statistical analysis only the first sample 
of each patient was used. 
Methods of determining the one-dimensional L/S ratio and the to­
tal lung profile are described in chapter 7.1 and chapter 8.1. 
8.3. Comparison between the one-dimensional L/S ratio, the two-
dimensional L/S ratio and the total lung profile 
First we analysed the correlation between the one-dimensional L/S 
ratio, the two-dimensional L/5 ratio and the gestational age at 
the time of sampling (Table VIII.II.). 
Table VIII.II. Correlation coefficients between one-dimensional 
L/S ratio (1D-L/5), two-dimensional L/S ratio 
(2D-L/S) and gestational age at the time of sam-
pl ing 
г 
ID-L/S versus menstrual age* 
2D-L/S versus menstrual age* 
ID-L/S versus 2D-L/S 
1D-L/5 vs. 2 D-L/5 controlled for menstrual age** 
0.61 
0.59 
0.90 
0.84 
menstrual age at sampling time 
** partial correlation coefficient 
As can be seen from table VIII.II, there is a good correlation 
between the ID-L/S and the 2D-L/S. The relationship between the 
two methods can be derived from table VIII.III. 
Table VIII.III. Comparison between the one-dimensional L/S ratio 
(ID-L/S) and two-dimensional L/S ratio (2D-L/S) 
2D-L/S 
< 1 
1 
I 
2 
> 
0 
5 
0 
2 
0 
-
-
_ 
5 
1 
1 
2 
4 
9 
4 
ID-L/S 
(mean value + SD) 
0 . 7 2 
1 . 1 5 
1 .79 
2 . 4 5 
4 . 7 6 
+ 
+ 
+ 
+ 
+ 
0 
0 
0 
0 
2 
17 
43 
40 
89 
14 
78 
Table Vili.IV. Samples of ID-L/S and 2D-L/S within 24 h of deli­
very 
ID-L/S 
<1.0 
1.0-1.4 
1.5-1.9 
>2.0 
2D-L/S 
<1.0 
1.0-1.4 
1.5-1.9 
>2.0 
η 
10 
13 
10 
58 
9 
16 
14 
65 
morbidity 
due to RDS 
1 
2 
1** 
2 
2 
1* 
1** 
mortalιty 
due to RDS 
1 
1 
2 
2 
1 
1*** 
mortality due to 
other causes 
3 
2 
1 
3 
4 
2 
1* 
4 
Morbidity due to RDS and mortality due to sepsis in the 
same neonate 
First born twin 
Second born twin 
Table Vili.Va Binary table model for the evaluation of the ID-L/S 
ID-L/S 
<1.5 
»1.5 
<2.0 
>2.0 
Respiratory distress 
present 
5 
1 
6 
0 
absent 
5 
18 
4 
67 
6 
27 
3 
58 
remarks 
sensitivity 
specificity 
pred. value 
pred. value 
sensitivi ty 
specificity 
pred. value 
pred. value 
= 0.83 
= 0.79 
immaturity 
maturity = 
= 1.00 
= 0.68 
immaturity 
maturity = 
= 0.22 
0.99 
= 0.18 
1.00 
(Numbers in the upper right corners represent the number of neo­
nates who died from causes other than RDS) 
Table VIII.Vb Binary table model for the evaluation of the 2D-L/S 
2D-L/S 
<1.5 
>1.5 
<2.0 
>2.0 
Respirator 
present 
8 
1 
4 
1 
10 
2 
y distress 
absent 
17 
75 
29 
63 
6 
4 
6 
remarks 
sensit ivity 
specificity 
pred. value 
pred. value 
sensitivity 
speci f ic ι ty 
pred. value 
pred. value 
= 0.67 
= 0.82 
immaturity 
maturity = 
= 0.83 
= 0.64 
immaturity 
maturity = 
= 0.32 
0.95 
= 0.26 
0.97 
(Numbers in the upper right corners represent the number of neo­
nates who died from causes other than RDS) 
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We did not detect a systematic difference between the two me­
thods. Neither the difference (1D-L/S)-(2D-L/S) nor logarithmic 
fraction In (1D-L/S)/(2D-L/S) was correlated to the 2D-L/S or the 
In 2D-L/S ( r= -0.043 and r= 0.016). The mean difference between 
1D-L/S and 2D-L/S was 0.15 in 159 samples with a standard devia­
tion of 1.15 (range -3.3 to 5.2). 
A comparison was made between the 1D-L/5 and the 2D-L/S as an in­
dex of fetal lung maturity. Only those samples obtained within 24 
hours before delivery were included in this study (table VIII.IV. 
and VIII.V.). Besides the threshold value of 2.0 which is gene­
rally accepted and mentioned in the literature, we introduced a 
threshold value of 1.5. This was done in order to reduce the num­
ber of false immature predictions without decreasing the sensiti­
vity. 
PG standard 
0 
soluble 
lecithin 
fraction 
0 
origin 
• · 
PG standard origin 
О 
phosphatidyl 
cerebrosides glycerol 
0 0 phosphatidyl 
serine 
phosphatidyl ethanolamineQ 0 
phosphatidyl i n o s i t o l ^ л 
lecithin 
sphmgomyelmQ 
origin 
• 
figure 8.3.1. Result of the two-dimensional thin-layer chromato­
graphy 
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The total lung profile can be determined from the results of the 
two-dimensional TLC (figure 8.З.1.). Besides the 2D-L/S the PG 
content is a most important source of information which is deri­
ved from the total lung profile. The results of this study are 
shown in figure 8.3.2. 
precipitated lecithin % 
9 0 
8 0 
7 0 
6 0 
tSEM 
phosphatidylglycerol % 
2 0 
15 
10 
-? ? 
phosphatidylmositol 7o 
25 
20 
15 
10 
5 
— f 
<10 
(16) 
10-14 
(25) 
15-19 
(26) 
2 0 - 2 4 
(21) 
s 2 5 
(71) 
2D-L/S 
Figure 8.3.2. The total lung profile in relation to the 2D-L/S 
(number of samples in brackets). 
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In most oases PG seems to be present after the 35th week of preg-
nancy; up to that time PG is present only occasionally. As preg-
nancy progresses the concentration of PG increases and the PI 
content diminishes. The PG content is also related to the neona-
tal outcome (table VIII.VI.). 
Table VIII.VI. Binary table for the evaluation of the PG content 
Phosphatidyl-
glycerol 
absent 
present 
Respiratory 
present 
6 1 
12 
0 
distress 
absent 
8 
38 
2 
54 
Remarks 
Sensitivity = 1.00 
Specificity = 0.58 
Pred. value immaturity = 0.24 
Pred. value maturity = 1.00 
(Numbers in the upper right corner represent the number of neona-
tes who died from causes other than RDS. The number in the upper 
left corner represents the neonates who died from RDS). 
We also calculated the probability that PG is present in case of 
a known 2D-L/S (Table VIII.VII.). 
Table Vili.VII. Percentage that PG is present in relation to the 
two-dimensional L/5 ratio (55) 
2D-L/S % PG present 
< 1 . 0 0 
1.0 - 1.4 0 
1.5 - 1.9 3.8 
2.0 - 2.4 42.9 
>2.5 93.0 
If the 2D-L/S is between 2.0 and 2.4 PG is present in about 43!S 
of the samples. If the 20-L/S is 2.5 or more, PG is present in 
93$ of the samples. 
Compared with the ID-L/S, PG was first seen in a sample with a 
L/S ratio of 1.4. In samples with a L/S ratio under 2.0, PG was 
present twice and absent 16 times. If the ID-L/S was 2.0 or more 
PG was absent 10 times and present 78 times (fig. 8.3.3. 4 Table 
VIII.VIII.). 
Table VIII.VIII. Comparison between ID-L/S and presence or absen-
ce of phosphatidylglycerol. 
ID-L/S 
<1.0 
1.00 -
1.5 -
2.0 -
>2.5 
1.4 
1.9 
2.4 
phosphatidylglycerol 
present 
0 
1 
1 
14 
64 
absent 
6 
5 
5 
6 
4 
S PG present 
0 
20 
20 
70 
94 
82 
phosphatidylglycerol %-
250 
200 
150 
100 
50 
О 
Figure 8.3.3. Relationship between the phosphatidylglycerol con­
tent and the 1D-L/S 
In comparison with the data from the 2D-L/S measurements, PG is 
present earlier and in a higher concentration when 1D-L/S values 
are low. 
Both the values of the 1D-L/S and 2D-L/S from this study are com­
pared with the model subset from the retrospective investigation 
(chapter 7 ) . It can be concluded that the values correlate well 
with each other (fig. 8.3.4. and fiq. 8.3.5). 
8.4. Conclusions 
This study shows that there is a good correlation between the 1D-
L/S and the 2D-L/S. In some samples there was a remarkable dif­
ference between the two types of L/S ratios. This difference can 
partly be explained by the different cent ri fuget ion speeds used 
in the two methods. Besides a higher 1D-L/S value can be explai­
ned by a non-optimal separation between the lecithin spot and the 
PI spot in the one-dimensional thin-layer chromatogram. This can 
cause false mature 1D-L/S values. A systematic difference was 
however not detected. 
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In (1D-L/S) 
3 0 - ι 
2 0 
1 0 
0 0 
10 
ι ι ι ι ι ι ι ι ι ι ι ι ι ι ; ι ι ι ι 
2 0 0 210 2 2 0 230 240 2 5 0 2 6 0 270 2 8 0 290 
menstrual age in days 
Figure 8.3.4. Ln(lD-L/S) in relation to the menstrual age (solid 
lines are the Ρ2·5> P50 * P97-5 from the model subset). 
ln(2D-L/S) 
30 
20 
IO 
00 
10 
I I I I I I ' I I I I ' I I 1 I I I 
2O0 210 220 230 240 2 5 0 2 6 0 270 2B0 290 
menstrual age m days 
Figure fl. 3. •>. Ln(2D-L/S) in relation to the menstrual age (solid 
lines are the Ρ2·3> Р5П * Ρ97·5 from the model subset). 
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It is not useful to lower the threshold value of the L/S ratio 
from 2.0 to 1.5. 
The 2D-L/S is a valid index of fetal lung maturity, but by itself 
this index is not better than the 1D-L/S. However, in combination 
with the knowledge of presence or absence of PG (or the amount of 
PI if PG is still absent) a better estimate of lung maturation 
can be made. When PG was present there was no RD5 even if the L/S 
ratio was below 2.0. 
The PG content increased with the progression of pregnancy; after 
the 35th week (MA) PG is present in most amniotic fluid samples. 
At present the total lung profile is probably the best index of 
fetal lung maturity in those obstetrical and neonatal centers 
which have highly qualified laboratory personnel and equipment. 
Further evaluation of this test is, however, still necessary. 
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9. AMYLASE CONCENTRATION IN AMNIOTIC FLUID 
The search for a sensitive and speciFic indicator of fetal lung 
maturity has led to the investigation of a number of other sub-
stances in amniotic fluid. One of these is the amylase concentra-
tion in amniotic fluid (ACAF), which according to Fernandez de 
Castro et al. (1973) and de Grandi et al. (1979) was also an in-
dex of fetal weight and gestational age. The amylase test is 
simple to perform and more rapid than the chromatographic techni-
ques for assessing pulmonary maturity. This was the reason why we 
investigated the relationship between the amylase concentration 
and the L/S ratio.We also wanted to know whether the amylase con-
tent was an index of gestational age or of fetal weight. Of par-
ticular interest was the question whether the ACAF could be used 
successfully as a screening test for pulmonary maturity to reduce 
the number of chromatographic measurements needed and the conco-
mitant delay in clinical decision-making. 
9.1. Material and Methods 
The study was divided into two parts. First the amylase concen-
trations and the one-dimensional L/S ratio (1D-L/S) were compared 
using 32 consecutive samples of AF obtained by transabdominal am-
niocentesis. In the second part, the amylase concentrations and 
the results of the two-dimensional chromatography of the phospho-
lipids were compared using 106 consecutive samples oF AF obtained 
by amniocentesis or at amniotomy. Blood or meconium stained 
Fluids were excluded From this study. 
Amylase concentrations were determined by the procedure oF 
Fernandez de Castro et al. (1973). This procedure is based upon 
hydrolysis of a water-insoluble cross linked blue starch polymer. 
The amylase in the test sample hydrolyzes this polymer into wa-
ter-soluble fragments. Since the absorbance of the blue-colored 
solution is a function of the amylase concentration, the concen-
tration can be calculated from the standard curve included with 
each batch of the polymer. 
The 1D-L/S was determined as previously described (chapter 7 . 1 ) . 
Details of the chromatographic technique employed for the 2D-L/S 
have been described in chapter 8.1. 
The critical value of ACAF for predicting fetal maturity (i.e. 
menstrual aqe >36 weeks, weight >2,500 g) was taken to be 200 U/l 
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(Fernandez de Castro et al., 1973). For correlation with the L/5 
results, the ACAF values were divided into three groups:<200 U/1, 
200-299 U/1, and 2:300 U/1, as suggested by de Grandi et al., 
(1979). 
The threshold value for both ID-L/S and 2D-L/S was taken to be 
2.0 (Gluck et al, 1971; Kulovich et al., 1979). Actual pulmonary 
maturity was based on clinical, biochemical and radiographical 
indications of RDS during the neonatal period. The duration of 
pregnancy at amniocentesis and delivery was calculated from the 
menstrual history supplemented,where necessary, by early ultraso­
nographic measurements. 
9.2. Amylase Concentrations and Gestational Age 
A significant correlation was found between ACAF and gestational 
age (r = 0.34, η = 105, ρ < 0.001). In Al of 105 AF samples, the 
ACAF was 200 U/1 or greater. All but 2 of these samples were ob­
tained from subjects having a menstrual age of 36 weeks or more 
(predictive value of maturity = 0.95). On the other hand, in 22 
of 61 AF samples the ACAF was 200 U/1, giving a total percentage 
of incorrect predictions of 24/105 (0.23). Increasing the criti­
cal value of ACAF to 300 U/1 and the menstrual age to 37 weeks 
increased the predictive value of the test to 1.0; however, the 
total percentage of incorrect predictions increased too (30/105 
incorrect predictions = 0.29). 
9.3. Amylase Concentrations and Fetal Weight 
68 subjects were delivered within 24 hours after the collection 
of the AF samples. In these cases there was a significant corre­
lation between ACAF and birth weight (r = Π.33, η = 68, p<.005). 
In 31 of 34 cases in which the ACAF was > 200 U/L, the birth 
weight was>2,500 g (predictive value = 0.91). 19 of the 50 fetu­
ses having birth weights >: 2,500 g had ACAF values <200 U/l.The 
total percentage of correct predictions using an ACAF threshold 
value of 200 U/1 in predicting the birth weight (more or less 
2,500 g) was 0.68 (46 of 68 cases were correctly classified). 
9.4. Amylase Concentration and ID-L/S 
The individual results of the determinations of ACAF and ID-L/S 
in 32 samples (phase 1) are shown in figure 9.4.1. In table IX.I. 
these values are tabulated according to the critical values des­
cribed earlier. 
B7 
amylase U/l 
600 
450 
300 
150-
- i — ι — ι I 
2 4 6 
-г
-
14 
- ι — ι — г 
16 18 
ID-L/S 
10 12 
Figure 9.4.1. Comparison between amylase content and 1D-L/S 
Table XI.I. ACAF and 1D-L/S ratios with respect to different cri­
tical values for prediction of pulmonary maturity 
Amylase Amylase Amylase 
<20n U/l 200-299 U/1 >:300 U/1 
L/S ratio <2.0 
L/S ratio >:2.0 
4 
11 
4 
10 
In only θ samples in this group was the L/S <2.0. These low va­
lues were associated with ACAF <200 U/1 (4 times) and >200 U/1 
(4 times). Only 3 samples had an ACAF >300 U/1, and in all 3 
samples the L/S was >2.0. 
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9.5. Amylase Concentrations and 2D-L/S 
Figure 9.5.1. is a scattergram of the ACAF and 20-1/5 values of 
the 106 AF samples. In table IX.II. the measurements are tabula­
ted according to the critical values. 
Table IX.II. ACAF and 2D-L/5 ratios with respect to critical va­
lues for prediction of pulmonary maturity 
Amylase 
<200 U/L 
Amylase 
200-299 U/l 
Amylase 
>:300 U/l 
L/S ratio <2.0 
L/S ratio >2.0 
34 
30 
4 
19 
0 
19 
amylase U/l 
1 0 0 0 
8 0 0 
6 0 0 
40O -
2 0 0 - -
η = 72 
• t Ino RDS as cause of death 
• PDS I none died 
·*. 3 ! -
• 105. 
+· 
7 2
 V ι 
* · 
96 
· · B2 
ι + 
•*91 
2 0 
τ 1— 
4 0 
— ι г 
6 0 
— ι г 
8 0 
2D-L/S 
F i g u r e 9 . 5 . 1 . C o m p a r i s o n b e t w e e n a m y l a s e c o n t e n t a n d 2 D - L / S 
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All 38 AF samples with L/S < 2.0 showed ACAF concentrations below 
300 U/1, and in 34 of the 38 samples the ACAF was <200 U/1. In 
30 of the 64 samples with ACAF <200 U/1, however, the L/S was 
>2.0. The L/S was >2.0 in all samples in which the ACAF was 
> 300 U/1. Prediction of L/S>2 from the ACAF test was thus 1.0 
if a threshold of 300 U/1 was introduced and 0.90 for an ACAF va­
lue >200 U/1. 
9.6. Amylase Concentrations, 2D-L/S and the Neonatal Outcome 
The AF sample was obtained within 24 h of delivery in 72 cases. 
Figure 9.6.1. shows the ACAF and 2D-L/S results in these cases in 
relation to the neonatal outcome. 
amylase U/1 
1000-,
 П
.-Ю6 
800 
600 
400 
200 
2D-L/S 
Figure 9.6.1. Comparison between amylase content and 2D-L/S in 
relation to the neonatal outcome. 
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Table IX.III. gives the distribution of ACAF and 2D-L/S according 
to the critical values, in relation to the neonatal outcome. 
Table IX.III. ACAF and the 2D-L/5 ratio as related to the 
neonatal outcome 
RDS present RD5 absent 
Amylase <200 U/1 1 26 
Amylase 200-299 U/1 1 15 
Amylase >300 U/1 0 23 
L/S ratio <2.0 2 10 
1/5 ratio >2.0 0 54 
6 cases in which the neonate died of causes other than RDS are 
included in the figure but omitted from the table. All 6 had ACAF 
values <200 U/1 and 4 had a 2D-L/5 <2.0. 
There were only 2 cases of RDS in infants with AF sampled within 
24 h of delivery. Both had a 2D-L/S <2.0 and the ACAF was < 300 
U/1; however, only 1 of the 2 had an ACAF <200 U/1. RDS occurred 
in 2 of the 15 cases with 2D-L/S < 2 . 0 (predictive value: 13.3%), 
but in only 2 of 49 cases with ACAF <300 U/1 (predictive value: 
4%) . 
9.7. Conclusion 
The findings of the present study confirm the observations of 
Fernandez de Castro et.al. (1973) and de Grandi et al. (1979) 
that the ACAF is related both to gestational age and fetal 
weight. Identification of a gestational age > 36 weeks and a 
birth weight >2,500 g could be performed with reasonable accura­
cy on the basis of an ACAF value >200 U/1 (predictive value 0.95 
and 0.91 respectively). However, the false negative rates were 
relatively high: 35% and 38%, respectively. Increasing the thres­
hold value to 300 U/1 is of no avail because the small decrease 
in false 'mature' predictions is associated with a much larger 
increase in false 'immature' predictions. 
ACAF values were also significantly correlated with the L/5 ra­
tios. Combining the findings from both parts of the study, 42 of 
50 samples with ACAF values > 200 U/1 had an L/S by either one-
dimensional or two-dimensional techniques of 2.0 or greater, with 
a predictive value of 0.Θ6 {χ2= 18, ρ < 0.0001). However, there 
were 8 false predictions of lung maturity and 1 of the 2 cases of 
RDS occurred in this group. In 41 of 79 AF samples with ACAF<200 
U/1, the L/S was >2.0 (false positive rate of 51$). Increasing 
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the critical value of ACAF to 300 U/1 eliminated the false nega­
tive results, but increased also the false positive rate to 60%. 
If the ACAF determination with a threshold value > 300 U/1 had 
been employed as a screening test, the L/S could have been omit­
ted in only 22 of the 13Θ samples (16%). This result shows clear­
ly that the ACAF test can not replace the L/S ratio. 
From these data the following conclusions can be drawnt 
(1) The ACAF test is positively correlated with both duration 
of pregnancy and fetal weight; however, the proportion of 
false predictions of lung immaturity based on a threshold 
values of ACAF of 300 U/1 is relatively high. 
(2) The occurrence of RDS in the study population could be mo­
re readily predicted from very low L/S ratios than from 
ACAF values. 
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10. ANIMAL MODEL FOR THE STUDY OF SURFACTANT FORMATION 
It is not always possible to study in the human the effect of 
drugs or other treatments on fetal pulmonary maturity, by exami­
nation of the amniotic fluid phospholipids. Several publications 
have shown that the fetoplacental unit of rhesus monkeys and ba­
boons is similar to that of the human with regard to the synthe­
sis of phospholipids (Gluck et al., 1974a; Epstein et al., 
1976a). However, Brans et al. (19Θ4) could not detect PG in am­
niotic fluid of baboons at term. 
The present investigation was carried out to obtain information 
about the change in the L/S ratio of amniotic fluid of the stump-
tail macaques (Macaca arctoides) during development (Feijen et 
al., 1979). This was followed by a study of the effect of Am-
(R) 
broxol on lung development (chapter 1 0 . 2 . ) . 
10.1. L/S ratio in Macaca arctoides 
10.1.1. Material and methods 
The animals were imported directly from Vietnam. After arrival at 
the animal laboratory, they were quarantined for 3 months for as­
sessment of qeneral health and for detection and elimination of 
tuberculosis, intestinal parasites, shigella and salmonella in­
fections. After this period the healthy female macaques were kept 
in individual cages. They received a daily diet consisting of 
about 150 g of a standard monkey chow (Hope Farms, G.O., Woerden) 
supplemented 2 or 3 times a week with mixed fruit. The tempera­
ture in the cage room was kept at 20-22*C and the relative humi­
dity was maintained at about 50-60%. An alternating 12-hour 
light-dark cycle was employed. The average menstrual cycle of 
these macaques is approximatley 30 days (Weber 4 Grauwiler, 
1972). Menstrual bleeding is not pronounced and varies from 1 to 
6 days. For matinq 1 male was used for 2 females. On day 1 the 
male macaque was placed with the female on his left and on the 
next day he was placed with the female on his riqht side etc. 
This sequence was maintained for 40 days. 
From the 17th day onward, the urine was tested every second day 
for the presence of monkey chorionic gonadotropin (mCG) by means 
of an agglutination technique (Hodqen 4 Griff, 1974). Between the 
18th and 25th day after conception, the concentration of mCG in 
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the urine of pregnant animals rises from 50 to 200 ID HCG 
(Tullner, 1971). The day on which mCG was first detected in the 
urine was taken to represent the 20th day of pregnancy. 
The nutrition of the pregnant monkey was the same as described 
for the non-pregnant animals. Pregnancy was confirmed by rectal 
palpation 20 days after the first detection of mCG and by an ab­
dominal X-ray 30 days later (i.e., at 70 days' gestational age) 
with measurements of the long-bones. 
The duration of pregnancy in these macaques varies between 168 
and 183 days (Trollope 4 Blurton-Jones, 1970). Stenger (1972) 
found an average pregnancy duration of 175 days, with a range of 
161-186 days. 
Nine monkeys were studied longitudinally during 10 pregnancies 
Transabdominal amniocenteses were done weekly under aseptic con-
(R) 
ditions. The monkeys were tranquilized with Vetalar w given intra­
muscularly (10 mg/kg body weight). The amniotic fluid was trans­
ported immediately to the laboratory and its phospholipids were 
measured by the same procedure as that developed for human sam­
ples (see table VII.I.). 
Table X.I. Number of amniocenteses and failures and outcome of 
pregnancy in each animal 
Monkey No. Number of Failures Neonatal Type of Gestational 
amniocenteses outcome delivery age, days at 
termination 
165 
170 
166 
170 
159 
166 
135 
176 
148 
48 
3 31 
J 48 
3 43 
3 63 
3 68 
3 35 
К 56 
3 57 
3 62 (2) 
5 
4 
6 
4 
3 
7 
β 
1 
8 
0 350g 
430g 
stillborn 
500g 
340g 
361g 
stillborn 
340g 
stil lborn 
S 
S 
S 
S 
5 
S 
5 
S 
A 
S = Spontaneous delivery; A 
section) . 
artificial delivery (= cesarean 
10.1.2. Results 
Amniocentesis was attempted 48 times in the 10 pregnancies. Am­
niotic fluid was obtained 41 times (failure rate: 14Й). The 
number of amniocenteses per preqnancy ranged from 1 to 8 (table 
X.I.). 
94 
Table X.I. also summarizes the outcome of the 10 pregnancies in 
the 9 monkeys studied. There were 6 live-born infant monkeys and 
4 stillbirths. The mean, birth weight of the live-born infants was 
386 g (range 340-500 g ) . Of the 4 stillbirths, 2 (both in monkey 
J-62) were caused by experimental fetal surgery unrelated to this 
investigation. 
The third fetal death (K-56) probably resulted from amniocente-
ses: 2 of the first 6 attempts yielded only blood, as did the 7th 
puncture. At the next amniocentesis, 1 week later, purulent fluid 
was obtained, and a week thereafter, the fetus was dead. Culture 
of the uterine contents revealed an intrauterine infection with a 
gram positive organism. The cause of the fourth fetal death 
(0-43) is uncertain. Amniocentesis was performed 5 times without 
comp 1 ications,the last one on day 156 of pregnancy. One week la-
ter the animal was anesthetized for fetal surgery. Amniocentesis 
then yielded red-brown fluid and by Doppler pulse detection no 
fetal heart activity was observed. A macerated fetus was deli-
vered spontaneously 3 days later. 
The results of the amniotic fluid L/S ratio determinations for 
the 10 pregnancies are listed in table X.II. and illustrated gra-
phically in figure 10.1. Although there were relatively few de-
terminations before 120 days' gestational age, the L/S ratio re-
mained at a low level during this period. After 120-125 days, the 
L/S ratio increased progressively with fetal age. The L/S ratio 
was 2.0 at 135 days in 1 animal, and values exceeding 2.0 were 
found in 3 other pregnancies on or before the 150th day. Another 
monkey (3-58), first sampled on the 151th day, had already an L/S 
ratio of 3.5. The slowest rise in the L/S ratio occurred in mon-
key 3-63, with a value of 1.2 at 157 days, followed by 3.0 at 164 
days. Two fetuses failed to achieve L/S ratios of 2.0 or greater; 
these fetuses died around the 107th and 142th day of pregnancy, 
respectively (K-56 and 3-62, first pregancy). Three fetuses sho-
wed a decline in L/S ratio towards the end of pregnancy: J-48, 
3-43 and 3-62 (second pregnancy). The fetus of 3-48 was live-born 
at term. The decrease in the L/S ratio in 3-43 occurred in asso-
ciation with fetal demise. The fetus of 3-62 (second pregnancy) 
was alive and apparently normal when the sample showing the de-
crease in L/S ratio was obtained. It subseguently died as a re-
sult of other operative manipulations. 
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Table Χ.II. Amniotic fluid L/S ratio during 10 pregnancies in 9 
M. arctoides 
Monke 
No. 
K56 
3 62 
α 35 
3 43 
У 
(2) 
Gestational 
age (days) 
72 
92 
100 
107 
107 
113 
120 
127 
134 
141 
14Θ 
117 
124 
131 
145 
152 
159 
128 
135 
142 
149 
156 
163 
L/5 ratio 
0.4 
0.7* 
0.4 
0.4 
0.7* 
0.4 
0.5 
0.8 
1.3 
2.2 
1.8 
1.5* 
0.9 
1.0 
2.6 
2.4 
3.3 
1.1 
2.0 
2.2 
2.6 
4.4 
1.5 
Monke 
No. 
331 
62 
63 
68 
48 
57 
У 
(1) 
Gestational 
age (days) 
134 
141 
148 
155 
162 
135 
142 
143 
157 
164 
143 
150 
157 
151 
165 
172 
172 
L/S ratio 
0.5 
0.6 
0.9 
1.9 
2.2 
1.0 
0.9 
0.4 
1.2 
3.0 
1.1 
2.1 
2.2 
3.5 
6.6 
2.4 
2.8 
* Blood stained sample 
L/S ratio 
70 
6 0 -
5 0 -
40 -
3 0 
20-1 
1 О 
Δ bloodstained 
t stillborn 
ΘΟ 100 120 
1 1 1 г 
140 160 1ΘΟ 
gestational age in days 
Figure 10.1.1. L/5 ratio vs. gestational age in Macaca arctoides 
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10.1.3. Discussion 
The results demonstrate that the developmental changes in the 
L/S ratio of amniotic fluid from M. arctoides are similar to tho-
se previously described in Macaca múllate (Peterson et al. 1972; 
Gluck et al., 1974a; Epstein et al. 1976a) and Papio papio 
(Kling, 1974; Gluck et al., 1974a; Kling 4 Kotas, 1975). In these 
primates, moreover, the L/S ratio follows a pattern similar to 
that observed in human pregnancy (low L/S levels until about 70%-
BOS of the gestational period has passed, followed by a progres-
sive rise until term). The period of maturation of surfactant 
synthesis, as shown by a rapid rise in the L/S ratio, may begin 
as early as 130-140 days. In 2 of the θ pregnancies however, a 
mature L/S ratio was not reached before the 150th day of gesta­
tion (0.85 of term). 
Kling 4 Kotas (1974, 1975) described in Papio a fall in the L/S 
ratio prior to term. One of the animals in the present study also 
exhibited a marked decrease in the L/S ratio, from 6.6 to 2.4, 
just prior to term. Another monkey exhibited a decrease of more 
than 50% in the L/S ratio in association with fetal death (cause 
unknown). A third monkey showed a fall in the L/S ratio from 2.2 
to 1.8 between the 141th and 148th day of pregnancy. Since this 
pregnancy was terminated before term, it is unknown whether the 
L/S ratio would have resumed its upward trend. 
The high pregnancy wastage in this series (4 of 10 fetuses) was 
largely iatrogenic. Two deaths were caused by fetal surgery and 
a third fetus died from infection probably introduced by amnio­
centesis. There was also one unexplained fetal death in late 
pregnancy. 
The findings indicate that the L/S ratio can be used in M. arc­
toides for predicting fetal pulmonary maturity. In particular a 
rapid rise in the L/S ratio before 130 days of pregnancy indica­
tes an increase in surfactant production by the fetal lungs. 
10.2 Influence of Ambroxol^- medication on the L/S ratio in Macaca 
arctoides 
A double-blind placebo controlled study was performed in the Ma-
R) 
caca arctoides to investigate the effect of Ambroxol medication 
on the L/S ratio. 
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10.2.1. Material and methods 
The study was done with 20 Macaca arctoides. The gestational age 
was determined with the aid of a chorionic gonadotropin assay. 
In the later period of gestation rectal examination and X-ray in­
vestigation of the pregnant animal and measurements of long-bones 
were also performed. 
Ambroxol w (0.5 ml/kg body weight) or a placebo (0.5 ml/kg body 
weight) were injected for the first time on day 115 (gestational 
age) or β little later. Then with an interval of 5 days the pro­
cedure was repeated until day 130. The monkey was sedated with 
(R) V e t a l a r w (10 mg/kg body weight i.m.) to facilitate amniocentesis. 
(R) Ambroxol or placebo was injected with the same needle with which 
the amniotic fluid sample had been gathered. Sometimes it was not 
possible to obtain amniotic fluid; nevertheless Ambroxol4-^ or pla­
cebo was injected according to the protocol. 
From all amniotic fluid samples the two-dimensional lung profile 
was determined as described (chapter 8 ) . 
10.2.2. Results 
The results of the 2-D L/S in relation to the gestational age at 
the sampling time are given in table X.III. Both the results of 
CR4-
the Ambroxol group and of the placebo group are given. The time 
of the first injection is called t 0; the numbers on the abscls 
are the time differences in days from t 0. 
Unfortunately data from 5 monkeys could not be used for the sta­
tistical analysis (lack of amniotic fluid, improper timing, fetal 
death). 
The mean values at the different periods are given in table 
X.IV. 
Table X.IV. Results of the two-dimensional L/S ratios in the 
Macaca arctoides (mean value + SD) 
рг Control group 
placebo (number) Ambroxol (number) table X.II 
0.41 + 0.11 (6) 0.42 + 0 . 2 0 (B) 
0.48 + 0.18 (6) 0.53 + 0.18 (5) 
Я 
e s t . a g e 
-5 -
t o 
J -
8 -
15 -
-2 
5 
11 
18 
21 - 26 
0.42 + 0.04 (4) 
0.79 + 0.44 (4) 
0.50 + 0.17 (8) 
0.56 + 0.26 (7) 
1.24 + 0.38 (6) 
1.43 + 0.76 (4) 1.30 + 0.89(6) 
In brackets the number of samples are given. t 0 is the moment of 
the first injection. 
Over the last period the mean value of the results from the study 
described in chapter 10.1 have been added. 
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1 
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Q. 
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φ 
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га 
α 
Table X.III. 2D-L/S from double-blind placebo controlled study in Macaca arctoides (t0= day 115 - 119 = mo­
ment of first injection; time schedule in days . The second and third injection are given in the periods ty 
and t2. it t3 and t4 another amniocentesis was performed.+ = moment of fetal death. The monkeys which could 
not be used for the statistical analysis are given in brackets). 
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Although the number of determinations is small, it can be conclu-
(R) ded from the data that Ambroxol injected intraamniotically, in 
the given dose does not increase the L/S ratio with respect to 
the placebo group. Even a late effect could not be detected since 
up to day 136 to 140 (gestational aqe) there was no difference 
(R) between the mean L/S ratio in the Ambroxol group end data 
gathered in the first part of the study (see chapter 1 0 . 1 ) . 
,® 
10.2.3. Conclusion 
The data presented here indicate that Ambroxol4^ administration 
does not stimulate fetal lung maturation, as reflected by an in-
crease in the L/S ratio. The determination of the total lung pro-
file did not add any further information while only three times 
PI was detected and never PG. This last observation is in accor-
dance with the work of Brans et al. (1984) in baboons. The data 
presented here also do not support the publications in which a 
positive effect of Ambroxol administration on the L/S ratio was 
reported. Further investigation is needed before its administra-
tion in the human is justified. 
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11. SUMMARY 
In the introduction some historical reports and data from the li-
terature are given. The aims of this study are described. It con-
sists of four parts: 
1. a retrospective study of the L/S ratio in complicated and un-
complicated human pregnancies was made and compared with data 
from the literature; 
2. a description of the total lung profile including the 2D-L/5 
is given and the method is compared with the one-dimensional 
L/S ratio; 
3. an evaluation of the value of the amylase content of amniotic 
fluid in predicting lung maturity; 
4. studies using Macaca arctoides were performed in order to de-
termine the influence of Ambroxol medication on the 2D-L/S of 
amniotic fluid. 
In chapter 2 the embryology and anatomy of the fetal lung is des-
cribed. Attention is given also to fetal breathing movements as 
far as they are related to lung development and surfactant syn-
thesis. 
Moreover the biochemical pathways of the production of phospholi-
pids are discussed as well as the source and composition of these 
substances. 
Chapter 3 deals with the description of the respiratory distress 
syndrome. Additional conditions leading to the respiratory dis-
tress syndrome are also described. Some data from the literature 
about the incidence of morbidity and mortality due to RDS and re-
lated to both the gestational age and the birth weight are summa-
rized . 
Chapter 4 deals with fetal pulmonary maturation. Several tests 
which could indicate the grade of lung maturity are discussed. 
There is evidence from the literature that the L/S ratio or, bet-
ter still, the total lung profile is at present the most reliable 
parameter for establishing fetal lung maturation. However, the 
determination of the lung profile is a time consuming procedure. 
It is therefore worthwile to search for an easier and faster 
test. 
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Chapter 5 offers data from the literature about drugs which may 
accelerate fetal lunq maturation: corticosteroids, beta adrener-
(R) gic drugs, thyroxine and Ambroxol . 
In chapter 6 an overview is given on replacement of surfactant in 
the lung of the neonate. Despite all efforts of the obstetrician 
to reduce the incidence of ROS in the newborns, the neonatologlst 
is still confronted with the problem of RDS and with Its seque­
lae. This justifies extensive investigations on the prevention of 
RDS with the aid of surfactant replacement therapy. 
In chapter 7 a description of a statistical model Is given. By 
means of this statistical model it was possible to compare the 
different groups of patients. It is based on data from a retro­
spective study of human pregnancies. 
The results from different groups are given and compared with da­
ta from the literature. From this study it can be concluded that: 
- the L/S ratios are only higher in diabetic pregnancies and dur­
ing beta adrenergic medication. Hypertension in the mother and/ 
or fetal growth retardation do not cause the L/S ratio to in­
crease ; 
- at a same menstrual age the inter-individual variation in the 
L/S ratios is large; 
- the L/S ratio in multiple pregnancies is higher than in single­
ton pregnancies at the same menstrual age; however the second 
born twin has a greater risk of developing RDS. 
In chapter В the results of the determination of the total lung 
profile from amniotic fluid is described. Data from the literatu­
re suggest that this method has a better predictive value for es­
tablishing fetal lung maturation than the L/5 ratio. We too have 
made a comparitive study of the one-dimensional L/S ratio and the 
two-dimensional L/S ratio. 
We did not find a systematic difference between the two methods. 
The two-dimensional L/S ratio in combination with the total lung 
profile and the estimation of the amount of PI and PG gave the 
most reliable information concerning fetal pulmonary maturation. 
We also made a comparison between the amylase concentration in 
amniotic fluid and (1) the menstrual age, (2) the L/S ratio and 
(7) the neonatal outcome (chapter 9 ) . There was a good correla-
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tion both with menstrual age and with fetal weight. The amylase 
content correlates also with the L/S ratio. However the high pro-
portions of false low L/S predictions makes the simple determina-
tion of the amylase concentration of amniotic fluid unsuitable as 
a substitute for the L/S ratio. 
In chapter 10 the gestational change in the L/S ratio of amniotic 
fluid in Macaca arctoides is described. We present evidence that 
the L/S ratio in Macaca arctoides undergoes similar developmental 
changes as in the human. We have studied the effect of intraam-
niotic Ambroxol medication on the L/S ratio in this monkey but 
were unable to detect any influence of this drug on the lung ma-
turity test. In the total lung profile PG was never detected in 
the Macaca arctoides. 
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SAMENVATTING 
De inleiding bevat naast enige historische gegevens een overzicht 
van de literatuur. Daarna wordt het doel van deze studie weerge-
geven. De studie omvat vier onderdelen: 
1. een retrospectief onderzoek betreffende de L/S ratio bij de 
mens zowel bij gecompliceerde zwangerschappen als niet-mani-
fest abnormale zwangerschappen. De verkregen gegevens worden 
vergeleken met resultaten uit de literatuur, 
2. een beschrijving van het totale longprofiel, een vergelijkend 
onderzoek met de een-dimensionale L/S ratio en de waarde ven 
beide onderzoeksmethoden met betrekking tot de voorspelling 
van de longrijpheid, 
3. een beoordeling van de waarde van de amylase concentratie in 
het vruchtwater in relatie tot de longrijpheid, 
4. een dierexperimenteel gedeelte omvattend het verloop van de 
L/S ratio bii de Macaca arctoides en de invloed van de toedie-
ning van Ambroxol op dit verloop. 
In hoofdstuk 2 wordt de embryologie en de anatomie van de foetale 
long beschreven. Tevens wordt aandacht geschonken aan adembewe-
gingen voor zover deze van invloed zijn op de longrijping. Ver-
volgens wordt de biochemie besproken waarbij de herkomst, de sa-
menstelling en de synthese van de phospholipiden aan de orde ko-
men . 
Hoofdstuk 3 omvat de beschrijving van de hyaline membranen ziek-
te. Tevens wordt melding gemaakt van enige situaties die aanlei-
ding kunnen geven tot het ontstaan ervan. Literatuurgegevens om-
trent het voorkomen van de hyaline membranen ziekte gerelateerd 
aan de zwangerschapsduur en geboortegewicht worden vermeld. 
In hoofdstuk 4 worden de meest bekende vruchtwater onderzoeksme-
thoden besproken die inzicht kunnen verschaffen in de mate van 
longrijpheid van de foetus. Het lijkt duidelijk dat de L/S ratio 
of nog beter het totale longprofiel tot op heden de meest be-
trouwbare parameter is. Echter gezien het tijdrovende facet van 
deze procedure is het de moeite waard om te blijven zoeken naar 
nieuwe methoden. 
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Hoofdstuk 5 geeft een beschrijving van een aantal geneesmiddelen 
waarvan in de literatuur een positief effect op de longrijping 
wordt beschreven. Corticosteroiden, betamimetica, thyroxine en 
Ambroxot""^ worden in dit verband besproken. 
In hoofdstuk 6 wordt een overzicht gegeven van de huidige stand 
van zaken met betrekking tot het postnataal toedienen van surfac-
tant. Ondanks alle pogingen van de obstetric! om het vóórkomen 
van RDS te verminderen zal de neonatoloog altijd geconfronteerd 
blijven worden met kinderen lijdende aan RDS en de restverschijn-
selen ervan. Dit rechtvaardigt onderzoek naar de mogelijkheden om 
surfactant postnataal toe te dienen zowel natuurlijk als kunstma-
tig surfactant alsook een combinatie van beide. 
Hoofdstuk 7 omvat de retrospective studie bij de mens. Allereerst 
wordt het statistische model beschreven dat gebruikt is om een 
vergelijking tussen de verschillende groepen patiënten mogelijk 
te maken. Daarna volgt een opsomming van de resultaten verkregen 
in de verschillende onderzoeksgroepen. Deze uitkomsten worden 
vergeleken met de literatuurgegevens. Uit deze studie kan gecon-
cludeerd worden dat: 
- alleen in zwangerschappen gecompliceerd door diabetes mellitus 
en in zwangerschappen waarin betamimetica werden gebruikt hoge-
re L/S waarden gevonden werden; van hypertensie en/of groeiach-
terstand kon geen longrijping bevorderend effect worden aange-
toond, 
- de inter-individuele variatie van de L/S ratio bij eenzelfde 
zwangerschapsduur groot is, 
- de L/S ratio in meerlingzwangerschappen hoger is dan in een-
lingzwangerschappen bij dezelfde zwangerschapsduur. Toch is het 
risico op het krijgen van RDS met name voor het tweede kind van 
een tweeling groter zelfs bij hoge L/S ratios. 
In hoofdstuk 8 wordt het totale longprofiel beschreven. Enige li-
teratuurgegevens suggereren een betere voorspelling van de mate 
van longrijpheid met deze methode. De bepalingsprocedure wordt 
beschreven. Een vergelijkend onderzoek tussen de een-dimensionale 
L/S itio en het totale longprofiel leerde dat een systematisch 
verschil tussen de een-dimensionaal en twee-dimensionaal bepaalde 
L/S ratio niet kon worden aangetoond. De twee-dimensionaal be-
panlrie L/S ratio in combinatie met het verdere lonqprofiel, met 
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name de hoeveelheid phosphatidylinositol bij afwezigheid van 
phosphatidylglycerol of de aanwezigheid van phosphatidylglycerol, 
kan een betere indruk geven omtrent de mate van longrijpheid. 
Een vergelijkend onderzoek tussen de amylase concentratie in het 
vruchtwater en de zwangerschapsduur, de L/S-ratio en de conditie 
van de neonatus bij de geboorte is beschreven in hoofdstuk 9. Er 
bestaat een goede correlatie zowel met de zwangerschapsduur als 
met het geboortegewicht. Ondanks een goede correlatie met de 
1D-L/S en 2D-L/S ratio blijkt de amylase bepaling ongeschikt om 
vast te stellen of de meer tijdrovende L/S ratio bepaling uitge-
voerd moet worden. 
In hoofdstuk 10 worden de dierexperimentele onderzoekingen be-
schreven. De L/S-ratio bij de Macaca arctoides vertoont een iden-
tiek verloop als bij de mens. Het tweede gedeelte van dit hoofd-
stuk omvat een studie betreffende de invloed van Ambroxol medi-
catie op het verloop van de L/5-retio. Een positief effect kon 
niet worden aangetoond. Verder was PG in het vruchtwater van de 
Macaca arctoides nimmer aantoonbaar. 
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13. APPENDICES 
Appendix 1. Two-by-two matrix of diagnostic test results. 
(McNeil et al. 1975) 
Abnormal 
condition 
Normal 
condition 
Total 
Abnormal test 
result 
Normal test 
result 
b + d 
Total a + b с + d a+b+c+d=n 
Sensitivity = a/(a+b). Specificity = d/(c+d) 
Predictive value of an abnormal test result = a/(a+c) 
Predictive value of a normal test result = d/(b+d) 
Incidence of abnormal condition = (a+b)/n. 
True positive result = a/(e + c) 
True negative result = d/(b + d) 
False positive result = c/(a + c) 
False negative result = b/(b + d) 
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Appendix 2 Inference in two-phase regression 
Estimates of the modelparameters T 0 , θ 0 , θ , and σ are obtained 
according to the method described by Hinkley (1971). 
Because the regression sum of squares before the 33th week of 
pregnancy was maximal and practically constant (figure 1 ) , the 
change-over point T 0 can be chosen anywhere before this time. 
regression sum of squares 
32 
2Θ -
24 
20 
16 
12 
F i g u r e 1 . R e g r e s s i o n sum 
of s q u a r e s f o r t w o - p h a s e 
r e g r e s s i o n i n t e r s e c t i n g 
at t = t o (model s u b s e t 
d a t a , η = 267) 
-τ—ι—г τ
-1—ι—ι—ι—ι—ι—ι—ι—ι—ΓΗ 
2Θ 30 32 34 36 3Θ 40 42 
menstrual age in weeks 
From the literature the T 0 is best chosen at 210 days. This value 
results in a L/S ratio of about 1.Π which fits well with the cli­
nical experience (Table I ) . 
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Table I.: Influence of choice of T 0 on some aspects of the two-
phase regression model, (model subset data, N= 267) 
Chanqe-over regression sum of 
point after squares for two-
л
 phase regression
 л 
Week To intersecting at t=To π 
central level L/S 
ratio in the first 
phase 
median mean 
29 203 
30 210 
31 217 
32 224 
3 1 . 0 6 
3 1 . 1 1 
3 1 . 0 7 
3 0 . 5 1 
2 
8 
13 
22 
0.Θ2 
0 . 9 5 
1 . 0 7 
1 .22 
0 . 9 9 
1 . 1 4 
1 . 2 9 
1 . 4 7 
η = number of observations in the first phase 
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Appendix 3. Preparation of TLC plates 
Pyrex plates are washed with a cleanser, rinsed well, and dried 
with a towel or in the oven. Paper towels are spread on a bench, 
and the plates are spaced about 5 inches apart. Two layers of 
half-inch Time tape, about half a tape's width, are placed on 
the left and right edges of 20x20 cm plates. Wrinkles should be 
avoided. The tape is allowed to overlap onto the towel, securing 
the plate to the towel. Two layers of tape, approximately 200 mi-
crons thick, represent the desired depth of silica gel coating. 
Thirty-five grams of silica Gel H are placed in a 250 ml 
Ehrlenmeyer flask and 65 ml of a 5% ammonium sulfate solution is 
poured slowly into the dry silica gel, which is then covered with 
paraplaat or Saran wrap. If the consistency is too heavy after 
shaking, ammonium sulfate solution may be added in 1 ml. portions 
until the consistency is like that of heavy ketch-up. The flask 
is shaken until the slurry is smooth. A one inch band of slurry 
is poured across the upper end of the prepared plate. 
The slurry is spread over the plate with a glass rod, working 
down and up, without pushing the silica gel off the plate, until 
the layer is even and smooth. Then with one stroke the silica gel 
is brought evenly to the bottom of the plate. The excess is 
pushed off onto the towel. 
When the gel in the plates sets to a mat finish, the tape is pee-
led off and the silica gel cleaned from the edges with a spatula. 
The thin layer plates are placed in a rack and left to dry over-
night; they must be activated at 100'C for 30 minutes before use. 
The plates should be stored in airtight dessicator cabinets after 
activation or they should be activated just before use. This 
method of making plates is both inexpensive and practical. 
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STELLINGEN, 
behorende bij het proefschrift: 
"ON THE DETERMINATION OF FETAL LUNG MATURATION" 
H.W.H. Feijen,11 januari 1985. 
1.Ter d e t e c t i e van veranderingen in de phospho-
l ipid-samenstel] ing van vruchtwater i s de aap 
geen optimaal dierexperimenteel model. 
2.Bij het toepassen van de nieuwe mogelijkheden 
van de moderne informaticatechnologie dienen 
bedrijven en inste l l ingen l e r i n g te trekken 
u i t de gevolgen die waarneembaar waren bi j een 
weinig mensgerichte aanpak bi j de technologi­
sche ontwikkelingen in het verleden. 
3.Het " s t r ippen" van de onderste eipool i s een 
kunstfout. 
4.Variuiii et mutabile semper f emina. 
(Verg. Λen. 2,354) 
5.Het toekennen van een bevoorrechte p o s i t i e 
aan univer s i te i t sk l in ieken voor de specia­
l i s t e n o p l e i d i n g i s geenszins een waarborg 
voor een optimale opleiding. 
6.Het inenten van zuigelingen dient b i j voor­
keur in de ochtenduren p laa t s t e vinden. 
7.bit oogpunt van infecticprofylaxe kan het pre-
operatief scheren van het toekomstige wondge-
Dicd achterwege gelaten worden. 
(Lancet, juni 1933) 
8.Bij de huidige discussie over de mankracht-
problematiek in diverse medische specialis-
men staan hun organisaties voor een strate-
gisch dilemma.De discrepantie tussen de op-
vattingen van (potenti'êle) patiënten, af stu-
derende specialisten en reeds werkzame col-
legae vraagt om een radicale strategische 
keuze. 
9.Magna res est vocis et silentii tempora 
noscere. 
(Pseudo-Seneca,De moribus 74) 
10.Het sollicitatieproces voor artsen is een 
klompendans waarbij diegene die de klomp 
past hem niet altijd mag aantrekken. 
11.Gezien het grondbeginsel van carnaval dient 
e e 
de 11 van de 11 tot een internationaal er-
kende feestdag te worden verheven. 
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